Capillary-based analytical technique developments for analysis of bio-sample by Chen, Huang
  
UNIVERSITY OF OKLAHOMA 
 
GRADUATE COLLEGE 
 
 
 
 
 
 
 
CAPILLARY-BASED ANALYTICAL TECHNIQUE DEVELOPMENTS FOR 
ANALYSIS OF BIO-SAMPLE 
 
 
 
 
 
 
A DISSERTATION 
 
SUBMITTED TO THE GRADUATE FACULTY 
 
in partial fulfillment of the requirements for the 
 
Degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
 
 
 
 
By 
 
HUANG CHEN 
 Norman, Oklahoma 
2017 
 
 
 
 
 
CAPILLARY-BASED ANALYTICAL TECHNIQUE DEVELOPMENTS FOR 
ANALYSIS OF BIO-SAMPLE  
 
 
A DISSERTATION APPROVED FOR THE 
DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY 
 
 
 
 
 
 
 
 
BY 
 
 
 
    ______________________________ 
Dr. Shaorong Liu, Chair 
 
 
______________________________ 
Dr. Jizhong Zhou 
 
 
______________________________ 
Dr. Zhibo Yang 
 
 
______________________________ 
Dr. Robert L. White 
 
 
______________________________ 
Dr. George B. Richter-Addo 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by HUANG CHEN 2017 
All Rights Reserved. 
 
iv 
Acknowledgements 
I would like to thank Dr. Shaorong Liu for mentoring me in these six years. I 
really appreciate all help and support I got from him. Without these support, I really 
could not finish my doctoral degree and find a job after graduation. He taught me not 
only how to be a good analytical chemist but also how to be a good man, which will 
benefit all my life. 
 
I would like to appreciate all of help and training from Mrs. Joann Lu. With her 
help, I learned how to operate a variety of instruments including ESI-MS, MALDI-MS, 
HPLC and LIF. She also shared her best knowledge with me and helped me solve 
problems in my research.  
 
I would like to thank Dr. Zhibo Yang, Dr. George Richter-Addo, Dr. Robert 
White, and Dr. Jizhong Zhou for being in my advisory committee. Your kind guidance 
are greatly appreciated.  
 
I would like to thank Dr. Qiang Liu for giving me an internship in ARL. This 
opportunity opened my eyes to industrial research and pharmaceutical industrial 
regulations. 
 
I would like to appreciate the help from my former and present group members: 
Dr. Congying Gu, Dr. Wei Wang, Dr. Lei Zhou, Dr. Min Zhang, Dr. Haiqing Yu, Dr. 
Xiaochun Wang, Dr. Jiangtao Ren, Aaron Morgan, Apeng Chen, Yu Yang, Kyle Lynch, 
v 
Piliang Xiang, Matthew Beckner, and Mitchell Weaver. I specially thank Dr. Zaifang 
Zhu, who is my good tutor. 
 
I would like to thank my parents for the encourage and love, which always help 
me face challenges and problems. I want to dedicate this dissertation to my wonderful 
wife Zhenzhen Qiao for her understanding when I worked very late in lab, for her 
sacrifice to take care of our home alone, and for love and support to help me complete 
this dissertation.  
  
vi 
Table of Contents 
Acknowledgements ......................................................................................................... iv 
Table of Contents ............................................................................................................ vi 
List of Tables ................................................................................................................... xi 
List of Figures ................................................................................................................. xii 
Abstract .......................................................................................................................... xiv 
Chapter 1: Introduction ..................................................................................................... 1 
1.1 Background ..................................................................................................... 1 
1.2 DNA separation .............................................................................................. 2 
1.2.1 Conventional DNA separation ................................................................. 3 
1.2.2 Free solution DNA separation .................................................................. 4 
1.3 Capillary Isoelectric Focusing (CIEF) ............................................................ 5 
1.3.1 Process of CIEF ........................................................................................ 5 
1.3.2 Carrier Amholytes .................................................................................... 6 
1.4 Two dimensional (2D) HPLC ........................................................................ 7 
1.4.1 Conventional configurations of 2D-HPLC .................................................. 8 
1.5 capillary liquid chromatography ................................................................... 10 
1.5.1 Open tubular capillary ..................................................................................... 11 
1.6 Dissertation Synopsis ......................................................................................... 12 
Chapter 2 Integrating multiplex PCR and bare narrow capillary – hydrodynamic 
chromatography for on-line DNA analysis ........................................................ 14 
2.1 Introduction ........................................................................................................ 14 
2.2 Experimental section .......................................................................................... 15 
vii 
2.2.1 Materials and reagents ............................................................................... 15 
2.2.2 Apparatus ................................................................................................... 16 
2.2.3 Preparation of chip injector ....................................................................... 21 
2.2.4 Capillary surface modification for capillary PCR amplification ............... 22 
2.2.5 Capillary PCR ............................................................................................ 22 
2.2.6 Performing multiplex PCR, on-line YOYO-1 intercalation, and BaNC-
HDC separation ...................................................................................... 24 
2.3 RESULTS AND DISCUSSION ......................................................................... 25 
2.3.1 Characterization of on-line DNA–YOYO-1 intercalation ........................ 25 
2.3.2 Incompatibility of YOYO-1 with PCR ...................................................... 30 
2.3.3 Demonstration of integrating multiplex PCR, on-line injection, BaNC-
HDC separation, and on-line DNA-YOYO-1 intercalation. .................. 32 
2.3.4 Calculation of the three multiplex products length ................................... 35 
2.4 Conclusions ........................................................................................................ 37 
Chapter 3: Simple means for fractionating protein based on isoelectric point without 
ampholyte ........................................................................................................... 38 
3.1 Introduction ........................................................................................................ 38 
3.2 Experimental section .......................................................................................... 42 
3.2.1 Reagents and Materials .............................................................................. 42 
3.2.2 Capillary coating ....................................................................................... 43 
3.2.3 Bradford assay ........................................................................................... 43 
3.2.4 Sodium dodecylsulfate – polyacrylamide gel electrophoresis (SDS-PAGE) 
of fractionated sample ............................................................................ 44 
viii 
3.2.5 Preparation of soluble protein extract from Hela cell ............................... 44 
3.2.6 Preparation of protein complex from Hela cell mitochondria ................... 45 
3.2.7 Two-dimensional electrophoresis (2DE) of fractionated sample .............. 46 
3.2.8 Apparatus ................................................................................................... 46 
3.2.9 Electrokinetic fractionation ....................................................................... 48 
3.3 Results and Discussion ....................................................................................... 48 
3.3.1 Suppression of electroosmotic flow (EOF) ............................................... 49 
3.3.2 Effect of Pharmalyte on MS signal ........................................................... 49 
3.3.3 DMI ........................................................................................................... 50 
3.3.4 pH variation in collection reservoir ........................................................... 51 
3.3.5 Protein recovery ......................................................................................... 52 
3.3.6 Electrophoresis time .................................................................................. 52 
3.3.7 Multi-level fractionation ............................................................................ 54 
3.3.8 Fractionation of Hela cell protein extract .................................................. 56 
3.3.9 MALDI-TOF-MS analysis of fractionated protein ................................... 57 
3.4 Conclusion .......................................................................................................... 58 
Chapter 4:  Two-dimensional chromatographic analysis using three second-dimension 
columns for continuous comprehensive analysis of intact proteins ................... 60 
4.1 Introduction ........................................................................................................ 60 
4.2 Experimental section .......................................................................................... 62 
4.2.1 Reagents and Materials .............................................................................. 62 
4.2.2 Preparation of Reverse-Phase (RP)-HPLC Monolith ................................ 63 
4.2.3 Preparation of Ion Exchange (IEX) Monolith ........................................... 63 
ix 
4.2.4 Sample Preparation .................................................................................... 64 
4.2.5 Online 2D HPLC Platform ........................................................................ 64 
4.2.6 2D HPLC Separation ................................................................................. 65 
4.3 Results and Discussion ....................................................................................... 66 
4.3.1 RP-HPLC separation ................................................................................. 66 
4.3.2 Column preparation for 2D HPLC ............................................................ 67 
4.3.3 Second-D separation speed consideration ................................................. 69 
4.3.4 Use of multiple columns to address second-D speed demand .................. 73 
4.3.5 Sample complexity reduction after 2D separation .................................... 73 
4.4 Conclusion .......................................................................................................... 74 
Chapter 5: A single pore liquid chromatography for high resolution and efficiency 
separation of peptides ......................................................................................... 85 
5.1 Introduction ........................................................................................................ 85 
5.2 Experimental section .......................................................................................... 87 
5.2.1 Reagents and Materials .............................................................................. 87 
5.2.2 Apparatus ................................................................................................... 87 
5.2.3 HPLC procedures ...................................................................................... 88 
5.2.4 Preparation of capillary ............................................................................. 88 
5.2.5 Fluorescence Labeling of Amino acids and peptides ................................ 89 
5.3 Results and discussion ........................................................................................ 89 
Chapter 6: Conclusion and future directions ................................................................ 100 
6.1 Conclusions ...................................................................................................... 100 
6.2 Future directions ............................................................................................... 101 
x 
References .................................................................................................................... 102 
 
 
 
 
  
xi 
List of Tables 
Table 2.1 DNA length (kbp) of multiplex PCR products. 
Table 4.1 Gradients used in the second dimension. 
 
 
 
xii 
List of Figures 
Figure 1.1 The profile of parabolic flow curve under the pressure driven condition. 
Figure 1.2 Schematic setup for CIEF. 
Figure 1.3 Illustration of the relationship between the peak capacities of the independent 
first and second dimensions in comprehensive two-dimensional separations. 
Figure 1.4 Schematic of setup used for fast 2DLC using high temperature and high 
velocity. 
Figure 1.5 Scheme of the instrument conﬁgurations. 
Figure 2.1 Schematic diagram of experimental setup for characterization. 
Figure 2.2 Schematic diagram of experimental setup for PCR-BaNC-HDC. 
Figure 2.3 The comparison of on-line labelled method and prelablled method. 
Figure 2.4 Repetitive run after single-time YOYO-1 charging. 
Figure 2.5 Resolution, efficiency and retention time varying with number of runs 
Figure 2.6 PCR of a tandem repeat (microsatellite marker) in Bioethanol 
Saccharomyces cerevisiae strain BG-1. 
Figure 2.7 Performing multiplex PCR, BaNC-HDC separation, and on-line dye 
intercalation on an integrated microfluidic platform. 
Figure 2.8 Curve-fitting results between DNA relative mobility and fragment length. 
Figure 3.1 Schematic representation of electrokinetic fractionation working principle. 
Figure 3.2 Apparatus for electrokinetic fractionation. 
Figure 3.3 Effect of Pharmalyte on MS signal. 
Figure 3.4 Effect of electrophoresis time on separation. 
Figure 3.5 Multi-level fractionation. 
xiii 
Figure 3.6 2DE results of soluble Hela cell proteins. 
Figure 3.7 MALDI-TOF MS of Intact proteins from fractionated mitochondrial 
complexes. 
Figure 4.1. Column-to-column reproducibility in RP HPLC. 
Figure 4.2 Batch-to-batch reproducibility in RP HPLC. 
Figure 4.3 Separation of protein lysates from E. Coli cells with RP HPLC. 
Figure 4.4 Testing the 2D HPLC platform with protein standards. 
Figure 4.5 Performance of IEX chromatography. 
Figure 4.6 Performance of RP HPLC. 
Figure 4.7 Separation of protein lysates from E. Coli cells using the 2D HPLC platform. 
Figure 4.8 Typical sample complexity after 2D HPLC separation.   
Figure 4.9 Schematic diagram of the new developed 2D-HPLC-UV/Vis platform. 
Figure 5.1 Schematic diagram of the single channel LC system. 
Figure 5.2 Comparison of isocratic and gradient elution. 
Figure 5.3 Effect of pressure on separation. 
Figure 5.4 Effect of gradient time on separation. 
Figure 5.5 Effect of separation pressure when gradient time is constant. 
Figure 5.6 Separation of mixture of BSA trypsin digest and Myoglobin trypsin digest. 
Figure 5.7 The effect of inner diameter of capillary on separation. 
xiv 
Abstract 
 
Analytical chemistry plays a significant role in bioscience research. Bio-samples, 
such as DNA and proteins, are often used for identification purpose or disease related 
research. Analyzing a biological sample typically includes sample preparation, 
separation, analyte detection and identification. Of these procedures, separation is the 
most essential procedure because bio-samples are usually very complicated. 
Unseparated sample makes it impossible to detect the molecule of interest. A successful 
separation should isolate the analytes from matrix, which may interfere with the 
accuracy, precision and sensitivity of the analytical method. The establishment of a 
separation technique should be specific to the features of analytes, including size, pKa, 
molecular weight, polarity, functional group, solubility, etc. This dissertation focuses on 
the development of various capillary-based separation techniques towards bio-samples. 
 
We have developed an innovative and simple approach for on-line intercalation 
of YOYO-1 with DNA. A capillary PCR with BaNC-HDC and this on-line intercalation 
approach were integrated onto a microfluidic platform. The feasibility of using this 
platform for multiplexed PCR, on-line intercalation of the amplified products, BaNC-
HDC separation, and LIF detection was demonstared. The microfluidic platform, 
combining with the PCR microfluidic chips and a miniaturized LIF, holds great 
promises for point-of-care applications. 
 
xv 
We have developed a simple electrokinetic means to fractionate protein samples 
according to their pI values and demonstrated the feasibility of using this approach for 
fractionating real-world samples. The method does not require sophisticated equipment, 
and its consumable costs are low. More importantly, the fractionated samples are MS-
friendly because we eliminate the use of ampholytes that interfere with MS analysis. 
The method will be an excellent way to purify a specific protein (e.g., an antibody) for 
analytical and micropreparative purposes. 
 
We have coupled IEX (the first-D) chromatography with multiple-column RP 
(the second-D) chromatography for comprehensive and 2D separation of intact proteins. 
With n columns incorporated in the second-D, we can theoretically reduce the speed 
requirement of the second-D by a factor of n. This system has been tested for separating 
both protein standards and E. Coli lysates; baseline resolutions were obtained for 
separating 11 standard proteins while more than 500 protein peaks were detected for the 
E. Coli lysate sample. 
 
We have developed a fast and exceptionally high efficient single pore capillary 
LC to resolve amino acids and peptides; in only ten minutes separation efficiencies of 
more than ten millions plates per meter are already obtained. We are going to combine 
this separation technique with MS to make an outstanding alternative technique to 
conventional LC-MS. 
1 
Chapter 1: Introduction 
 
1.1 Background 
Analytical chemistry plays a significant role in bioscience research. Bio-samples, 
such as DNA and proteins, are often used for identification purpose or disease related 
research. Analyzing a biological sample typically includes sample preparation, 
separation, analyte detection and identification. Of these procedures, separation is the 
most essential procedure because bio-samples are usually very complicated. 
Unseparated sample makes it impossible to detect the molecule of interest. A successful 
separation should isolate the analytes from matrix, which may interfere with the 
accuracy, precision and sensitivity of the analytical method. The establishment of a 
separation technique should be specific to the features of analytes, including size, pKa, 
molecular weight, polarity, functional group, solubility, etc. Chromatography and 
electrophoresis are two major separation systems. In chromatography, pump-driven gas 
or liquid flow drives the movement of analytes through the stationary phase for 
separation. Different stationary phases make various chromatography modes such as 
reverse phase, normal phase, ion exchange, size exclusion, etc. Hydrodynamic 
chromatography separates analytes by parabolic flow instead of a kind of stationary 
phase. High selectivity and reliability, and simple automation make chromatography 
most widely used. In electrophoresis, the analytes are electrically driven when they 
carry charges under a particular condition. The analytes with different mass to charge 
ratios can be separated in a free solution but analytes of similar mass to charge ratios, 
like DNA, can only be separated with the help of matrix, like gel. Gel electrophoresis is 
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often used for DNA, RNA and protein analysis but regular electrophoresis could not be 
automated and not precise enough for analysis of small molecules like drugs and 
metabolites. The advent of capillary electrophoresis (CE) makes the automation of 
electrophoresis possible and the properties of capillary allow low sample and solvent 
consumption, and allow high voltage application for high-efficiency separation.  The 
capillary electrophoresis chromatography (CEC) is a combination of electrophoresis 
and chromatography. These two different separation mechanisms combined can give a 
high efficiency and selectivity separation.  
The objectives of this dissertation were to develop capillary based analytical 
techniques to overcome the drawbacks of regular methods and to facilitate automation 
by integrating multiple offline steps to an online platform.  
 
1.2 DNA separation 
DNA separation and analysis are essential to molecular biological research. 
Among all bio-molecules such as amino acids and proteins, DNA is a large molecule 
containing genetic coding information, which determines the biological processes from 
birth to death1. DNA separation is the most important part in the DNA analysis, which 
often answers how DNA works. Nowadays, genetic information is used to diagnose a 
genetic disease; forensic field uses comparison of the DNA of suspect with that found at 
the scene to identify the real criminal; and DNA fingerprints of bacteria and fungi are 
used to identify the pathogen strain.  In all these applications, DNA separations are 
carried out.  
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Electrophoresis is the most widely used for DNA separations. When the voltage 
is applied, the negatively charged nucleic acids move toward the positive electrode. 
Because of presence of the sieve matrix of the gel, shorter DNA fragments travel more 
rapidly than longer fragments. Agarose gel is the most common material for the 
separation of a wide range of DNA (75-20,000 bp) while polyacrylamide gels can 
provide very high resolution of DNA molecules in the 10–3,000 bp size range. Without 
gel, DNA fragments larger than ~400 bp could not be resolved in free solutions2.   
 
1.2.1 Conventional DNA separation 
Since 1970s, gel-electrophoresis became commonly used for DNA separation in a 
slab-gel design3, which achieved good separations for a common DNA size range. The 
DNA fragments larger than 40-50 kb4 were separated by pulsed field gel electrophoresis 
(PFGE)5. These methods require time-consuming manual operation and produce 
excessive Joule heating. In order to improve the resolving power, lower separation time, 
and enhance the throughout, capillary gel electrophoresis was invented6. An array of 
parallel capillaries for gel electrophoresis has been developed for high throughput7. 
Automated multicapillary electrophoresis has completely changed the DNA sequencing 
method by replacing the labor-intensive slab gel electrophoresis. The capillary based 
conventional DNA separations require sieving gel, which introduces drawbacks 
including irreproducibility of gel preparation and high pressure for injecting gel into 
capillary.   
4 
1.2.2 Free solution DNA separation  
DNA separation in free solution was developed to get rid of problems related to 
gel. Based on the separation mechanism, they are electrophoresis in free solution and 
liquid chromatography for DNA separations. Electrophoresis in free solution separates 
species only based on their mass to charge ratio, so DNA cannot be separated because 
different DNA fragments have similar mass to charge ratio. To overcome this problem, 
the end of DNA molecule was labeled to make DNA of different size have different 
mass to charge ratios8, 9. High performance liquid chromatography was another attempt 
for DNA separation in free solution.  Ion-exchange chromatography 10 and reverse 
phase chromatography 11, 12 were developed based on interaction with anion-exchange 
resin and with nonpolar stationary phase respectively . However, resolving power of 
HPLC for DNA is not comparable to electrophoresis. The most recent attempt 
developed a novel DNA separation technique, called bare narrow capillary-open tubular 
chromatography. DNA molecules are separated in a very narrow capillary in the 
pressure driven flow. Large DNA molecules have bigger effective diameters and get 
further away from the capillary wall (slow flow rate region) than small DNA molecules 
as shown in the figure 1. This free solution technique provides separation of wide range 
of DNA size and high resolution comparable to electrophoresis.  
 
5 
  
Figure 1.1 The profile of parabolic flow curve under the pressure driven condition. 
The circles represent distribution of small DNA (small circle) and large DNA (big 
circle) in the parabolic flow.     
  
1.3 Capillary Isoelectric Focusing (CIEF) 
IEF is considered to provide best resolution among different separation 
techniques13. For this reason, it is selected as the first dimension of conventional two-
dimensional gel separation for proteomics. CIEF is the version of IEF occurring in a 
capillary, which only requires a small amount of sample and buffer consumption. Most 
importantly because of high resistance and wonderful heat dissipation, very high 
voltage can be applied across a capillary, which dramatically speeds up the focusing 
process. CIEF has been widely used for protein separation14-16 and determination of 
isoelectric point (pI) 17-19 because it provides excellent resolution of proteins with the 
advantage of on-line detection and automated operation.   
 
1.3.1 Process of CIEF 
In CIEF, protein sample is mixed with carrier ampholytes before they are 
introduced into capillary by pressure. The carrier ampholytes will generate a pH 
6 
gradient when voltage is applied. Analytes move in the capillary when they carry either 
negative or positive charges until they reach the position where pH equals to their pIs. 
On the specific pH spot, analytes spontaneously accumulate. After the focusing is done, 
the focused analytes are driven toward the detection window by either hydrodynamic or 
chemical mobilization.  The whole setup is briefly shown in figure 1.2. 
 
 
Figure 1.2 Schematic setup for CIEF 
 
1.3.2 Carrier Ampholytes 
For CIEF separation, carrier ampholytes are the essential part for generating a 
desirable pH gradient. In 1960s, the term of carrier ampholytes was put forward by 
Svensson, who discovered that under a voltage a stable pH gradient can be built by a 
mixture of different ampholyte compounds20. The composition of the carrier ampholyes 
is very complicated because they are the synthetic heterogeneous mixture of isomers of 
polyamino polycarboxlic acids21. To be distinguished from analytes, carrier ampholytes 
have unique properties, for example they are small molecules (1,000-15,000 Da) 
compared with proteins and they do not interfere UV detection. However, with ease of 
7 
ionization they seriously suppress the ionization of analytes when Mass spectrometer is 
used for detection and identification.  
 
1.4 Two dimensional (2D) HPLC 
The term “2D-HPLC” describes the technique in which two independent liquid 
phase separation systems are applied to the sample. The fractions from the first 
dimension are to be further separated in the second dimension for better resolution. If 
only the interesting portion of the first-dimension effluent is transferred to the second 
dimension it is referred to as “heartcutting” chromatography. If all fractions from first 
dimension are sequentially transferred in many small aliquots to the second dimension, 
it is known as “comprehensive” 2D chromatography. The true value of an ideal 
comprehensive 2D separation was pointed out as overall peak capacity (nc,2D) should 
be equal to the product of the individual peak capacities of the first and second 
dimension separations (1nc and 2nc, respectively)22, 23: (Shown in figure 1.3) 
                                                 22                                  
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Figure 1.3 Illustration of the relationship between the peak capacities of the 
independent first and second dimensions in comprehensive two-dimensional 
separations 
 
1.4.1 Conventional configurations of 2D-HPLC 
In the last decade, 2D-HPLC has received considerable attention. Erni and Frei 
started the online comprehensive 2DLC 24. Jorgenson and Bushey first applied 2D-
HPLC for protein separations25. Since then, a variety of 2D-HPLC separation methods 
had been developed for proteomics research26, 27. In 2006, a supra-ambient temperatures 
9 
(110 °C) and high linear velocities (>3 cm/s) on the second dimension column was 
developed by  Stoll et al. to speed up second dimension separations to about 20 s, and 
thereby the overall comprehensive 2DLC separation was reduced to about 30 min28. A 
schematic of the setup used for this work is shown in figure 1.4. In 2014, Angilent 
published 1290 Inﬁnity 2D-LC Solution with Diode Array Detection and Q-TOF 
LC/MS for analysis of E.coli Tryptic Digest, the configuration of which is currently the 
most common design shown in figure 1.5. Using this configuration, the fraction is 
immediately transferred into second dimension upon it is ready.  
 
   
Figure 1.4 Schematic of setup used for fast 2DLC using high temperature and high 
velocity28. 
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Figure 1.5 Scheme of the instrument conﬁgurations (http://www.agilent.com/en-
us/products/liquid-chromatography/extended-lc-systems-workflow-solutions/2d-
lc-solution/1290-infinity-ii-2d-lc-solution) 
 
1.5 capillary liquid chromatography  
The conventional liquid chromatography was miniaturized by using capillary for 
the analysis of nanoliter and subnanoliter samples. Packed, semi-packed, monolithic 
11 
and open tubular capillary columns have been developed for this purpose. Packed 
capillary is the mini version of the conventional column, but to pack a narrow capillary 
is very tedious and time consuming. Semi-packed capillaries are prepared by packing 
particles around 10-100 µm into capillary. Then the packed capillaries are drawn on a 
glass drawing machine to make the diameter of the capillary 2-3 times the diameter of 
the particles29. To prepare these columns with smaller inner tube diameters and smaller 
particle diameters is also difficult. Monolithic capillary columns are prepared by 
creating polymer in the capillary and the polymer serves as the stationary phase through 
their interaction with analytes11, 30. However, the polymer in different portions of 
capillary is likely to be nonuniform, which introduces high eddy diffusion to separation. 
In addition, to control the extent to which the polymerization occurs is challenging; over 
polymerization often causes the clog in the capillary, especially in narrow capillary with 
inner diameter of 5-10 µm. In this dissertation, open tubular capillary is the focus, 
which will be discussed in detail as follows. 
 
1.5.1 Open tubular capillary 
Open tubular columns were first applied in gas chromatography for high 
separation efficiencies. Later, the application of open-tubular columns in liquid 
chromatography received considerable attention. Knox, Gilbert and Guiochon discussed 
the theoretical aspects of open-tubular columns in their papers23, 31. Only small inner 
diameter capillary (5-20 µm) has been utilized for open tubular column because the low 
surface area to volume ratio of big open tubes causes low capacity and retention factor. 
Unlike the conventional matter, the stationary phase is directly bound to the inner wall 
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of the capillary rather than to particles packed into the capillary or column. The open 
capillary column has only one pathway, which eradicates the eddy diffusion caused by 
non-ideal packing in conventional chromatography. Small dimension also limits the 
longitudinal diffusion. All these features make open tubular column exceed the 
resolving power of modern HPLC packed columns. However, loading capacity is still 
problematic. To improve loading capacity, porous layer open tubular (PLOT) was 
invented by Tsuda et al. in 1978, using an i.d. of 60 µm32. The only difference between 
conventional open tubular and PLOT is the existence of a layer of polymers, which 
enhances the loading capacity by increasing the ratio of stationary phase to mobile 
phase. However, producing this layer of polymer is not practical in the very narrow 
capillary (i.d. ~5 µm).    
 
1.6 Dissertation Synopsis 
The objective of the dissertation is to develop capillary-based analytical 
techniques for bio-sample analysis.  Chapter2 will present a capillary-based set up for 
integration of PCR, DNA separation, DNA labeling and detection. The goal of this 
study is to develop a simple DNA analysis microfluidic platform as a key component of 
the portable setup for point of care applications.  
 
In chapter 3, we developed a simple means for fractionating protein based on 
isoelectric point without ampholyte. The goal of this study is to develop a simple 
protein fractionation method to purify a specific protein (e.g., an antibody) for 
13 
analytical and micropreparative purposes. And the final fractionated sample is MS-
friendly. 
 
In chapter 4, we developed a new 2D HPLC configuration by using parallel 
second-dimension columns for comprehensive analysis of intact proteins. The goal of 
this study is to demonstrate the advantage of the new design and applications for rea-
world sample. 
 
In chapter 5, a 2-µm-i.d. capillary liquid chromatography was developed for high 
resolution and efficiency separation of amino acids and peptides. The goal of this study 
is to first demonstrate the hyphenation of the narrow capillary with conventional HPLC 
pump for LIF detection. The second goal is to explore the high separation efficiency of 
extremely narrow capillary.  
 
Chapter 6 gives an overall summary and conclusion, and future directions of the 
achievement presented in the dissertation. 
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Chapter 2 Integrating multiplex PCR and bare narrow capillary – 
hydrodynamic chromatography for on-line DNA analysis 
 
2.1 Introduction 
Polymerase chain reaction (PCR) is widely used for analysis of a specific 
segment of DNA, or a DNA variation. Multiplex PCR is a variant of conventional PCR 
in which two or more loci are simultaneously amplified in the same reaction. Since its 
introduction in 198833, this technique has been utilized successfully in various areas of 
DNA analyses such as DNA deletion34, 35, mutation36 and polymorphism37, etc. 
Multiplex PCR can also be utilized to boost the sample throughput38-40 for strain 
identification. Analyzing the products of multiplex PCR is often carried out by 
electrophoretic separation40, or DNA melting curve analysis41. PCR and the following 
electrophoretic separation have been integrated42-45, but, because the gels used in the 
above integrated devices need to be replenished after each run to prevent the gels from 
being blocked by large DNA templates, performing the separations is tedious and time-
consuming. In this technical note, we describe a new approach to address this issue. We 
perform multiplex PCR inside a capillary tube, transfer the amplified fragments to a 
narrow capillary on-line, and measure their lengths by Bare Narrow Capillary – 
Hydrodynamic Chromatography (BaNC-HDC)46, a new technique developed in our lab 
for free-solution DNA separation. BaNC-HDC is capable of resolving DNA with a wide 
size range, and the separation is performed in a solution without any sieving matrices. 
PCR products can be injected directly into a BaNC-HDC column for separation without 
any purification (such as DNA template/enzyme removal, desalting, etc.).  
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To prepare a sample for BaNC-HDC separation, the PCR products need to be 
fluorescently labelled. Labelling these DNA can be accomplished by throwing a 
fluorescent intercalating dye in the solution either during the reactions if the dye (e.g., 
SYBR Green I) is compatible, or after the reactions if the dye (e.g., YOYO-1) is 
incompatible with the PCR. We focus on the latter in this experiment. To intercalate the 
DNA with YOYO-1, we flush the bare narrow capillary with a YOYO-1 solution; 
positively charged YOYO-1 is adsorbed (or charged) onto the negatively charged 
capillary wall. As DNA molecules are driven down the capillary column for separation, 
they react with YOYO-1 stored on the capillary wall and are on-line intercalated with 
the dye. With a single YOYO-1 charging, the column can be used for more than 40 
runs, although the fluorescence signal intensities of the DNA peaks decrease gradually. 
Although the dye-DNA intercalation occurs during the separation, it does not affect the 
retention times, separation efficiencies, or resolutions.  
 
2.2 Experimental section 
 
2.2.1 Materials and reagents 
YOYO-1 was purchased from Life Technologies (Grand Island, NY). A DNA 
ladder (1-kb plus), tris(hydroxymethyl)aminomethane (Tris), ethylenediaminetetraacetic 
acid (EDTA), and other common reagents were purchased from Fisher Scientific 
(Pittsburgh, PA). Fused-silica capillaries were purchased from Polymicro Technologies 
(Phoenix, AZ). 10.0 mM tris-EDTA (TE) buffer consisted of 10.0 mM Tris and 1.00 
mM EDTA, and its pH was adjusted to 8.0. All solutions were prepared using ultrapure 
16 
water (Nanopure ultrapure water system, Barnstead, Dubuque, IA), filtered through a 
0.22 µm filter (VWR, TX), and vacuum-degassed before use. 
 
2.2.2 Apparatus 
The experimental setup for characterizing on-line DNA and YOYO-1 
intercalation is schematically shown in Figure 2.1. A 50-cm capillary with an i.d. of 2 
μm was used for gel-free DNA separations. The inlet of the nanocapillary was inserted 
into a solution inside a pressure chamber. The pressure chamber was capped and sealed 
with a septum. The solution was driven into capillary by pressure-regulated nitrogen. 
The polyimide coating (~3 mm in length) was removed at a position ~10 cm away from 
the outlet end of the capillary to form a detection window. A laser-induced fluorescence 
(LIF) detector was used to monitor the DNA fragments passing through the window. 
The detector was built in our laboratory. Briefly, a 488 nm beam from an argon ion 
laser (LaserPhysics, Salt Lake City, UT) was directed by a dichroic mirror (Q505LP, 
Chroma Technology, Rockingham VT) and focused onto the detection window of the 
capillary via an objective lens (20×and 0.5 NA, Rolyn Optics, Covina, CA). The 
emitted fluorescence was collimated by the same lens, went through the same dichroic 
mirror, an interference band-pass filter (532 nm, Carlsbad, CA), a 1-mm pinhole and 
finally collected by a photosensor module (H5784-04, Hamamatsu). A measurement 
computing USB-1208FS (Measurement Computing, Norton, MA) was used to measure 
the output of the photosensor module. The data were acquired and analyzed using a 
program written in-laboratory with labview (National Instruments, Austin, TX). The 
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alignment of the detection window with the LIF detector was achieved via an x-y-z 
translation stage. 
 
To align the detection window with the LIF detector, a fixed pressure was applied 
to the pressure chamber to drive a fluorescein solution through the capillary at constant 
flow rate. While the fluorescence signal was monitored, the position of the detection 
window was adjusted via the x-y-z translation stage. The x, y and z positions of the 
translation stage were fixed once the maximum signal was achieved. Before charging 
the capillary with YOYO-1, the capillary was thoroughly washed with 1×TE buffer 
until the florescence signal reached the background level. The separation capillary was 
flushed with approximately ~4 nL of 7.0 µM YOYO-1 in 1× TE buffer and then ~4 nL 
of 1× TE buffer under a pressure of ~350psi. After a DNA sample was placed in the 
pressure chamber, a pressure of ~40 psi was applied to effect sample injection for 10 s. 
Then the sample was replaced with an eluent vial, and a pressure of 350 psi was applied 
to the pressure chamber to carry out the separation.   
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Figure 2.1 Schematic diagram of experimental setup for characterization. 
 
Figure 2.2 presents the apparatus used in this experiment to perform multiplex 
PCR, on-line DNA–YOYO-1 intercalation, and BaNC-HDC separation. The system 
consisted of a pressure chamber (PC), a chip injector (C), a PCR capillary and a 
thermocycler (TC), a six-port valve, a BaNC-HDC column, and a confocal laser-
induced fluorescence detector (D). The detailed descriptions of the pressure chamber, 
chip injector, and detector can be seen in Supporting Information (SI). The PCR 
capillary had a length of 2 m, and an i.d. of 75 μm, and it was treated with 
dichlorodimethylsilane and bovine serum albumin; the detailed treatment procedure is 
described in SI. TC is a MJ Research PTC-200 Peltier Thermal Cycler. A six-port valve 
was utilized in conjunction with the chip injector to facilitate sample injection for 
BaNC-HDC separation. The valve could be switched between an “open” position [as 
the PCR capillary from position 2 and auxiliary capillary from position 4 on the chip 
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injector were connected to sample (S) and waste (W)] and a “closed” position (as the 
above two capillaries were connected to blocked ports). The BaNC-HDC column was a 
fused silica capillary having a length of 55 cm and an i.d. of 2µm. 
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Figure 2.2 Schematic diagram of experimental setup for PCR-BaNC-HDC. (A) 
Experimental setup. S – sample, W – waste, C – microchip injector, PC – pressure 
chamber, and TC – thermocycler. The solid dots on the six-port injection valve 
indicate ports that are blocked. Capillaries are connected to positions 1, 2, 3, and 4 
on microchip injector are separation capillary, PCR capillary, pressure capillary, 
and waste capillary respectively. The separation capillary had a length of 55 cm 
(35 cm effective), an o.d. of 150 μm and an i.d. of 2 μm. The PCR capillary had a 
length of 2 m, an o.d. of 150 μm and an i.d. of 75 μm. The pressure capillary had a 
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length of 10 cm, an o.d. of 150 μm and an i.d. of 20 μm. The waste capillary had a 
length of 30 cm, an o.d. of 150 μm and an i.d. of 75 μm. (B) through (G) depict 
schematic diagrams for illustrating major operating procedures. The arrows 
indicate the flow directions (see details in text). 
 
2.2.3 Preparation of chip injector 
A chip injector was used in this experiment (see Figure 2.2) to implement sample 
injection and DNA separation. The chip injector (Figure 2.2C) consisted of a 
microfabricated cross channel inside a glass chip, and an off-chip six-port valve (Model 
7725i, IDEX Corporation, Lake Forest, IL). The cross channels in the chip were round 
and had a diameter of ~170 μm, which were produced using standard photolithographic 
technologies. Briefly, cross grooves were first created on two glass wafers. Because the 
cross pattern on a photomask had a line-width of 10 μm, the grooves were virtually 
semicircular after they were isotropicly etched to a depth of 85 μm. Two etched wafers 
were face-to-face aligned and bonded to form round channels. As shown in Figure2.2A, 
the separation capillary was connected to the chip cross at position 1,and PCR capillary, 
pressure capillary, and waste capillary were connected to the chip cross at positions 2,3, 
and 4, respectively. Epoxy adhesive was used to secure all capillaries in positions. The 
other ends of PCR capillary and waste capillary were connected to the six-port valve. 
The two solid dots on the six-port valve indicated that those ports were blocked. 
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2.2.4 Capillary surface modification for capillary PCR amplification 
To prevent reagent adsorption, the PCR capillary was silanized with 
dichlorodimethylsilane (DDMS) and coated with bovine serum albumin (BSA) 
according to the following protocol47, 48. After the capillary was flushed with acetone 
for half hour, it was filled with 1 M NaOH, with both ends being blocked by a silicone 
rubber stopper, and placed in an oven at 110 ℃ for 2 h. The capillary was then flushed 
with water, acetone, and dried with N2. After the capillary was filled with a 5% DDMS 
in chloroform, a vacuum was applied to evaporate the solvent, and a thin film of DDMS 
was formed on the capillary channel wall. The capillary was rinsed with 50 μL 
chloroform, 50 μL acetone and 50 μL water, successively. After the capillary was dried 
with N2, it was flushed with 50 μL of 1 mg/mL BSA at the flow rate of 0.12 μL/min, 
and then 20 μL water. 
 
2.2.5 Capillary PCR 
Three sequences from two different DNA methylases genes and one green 
fluorescent protein (GFP) were amplified simultaneously in capillary. DNA templates 
were three plasmids, two of which contain different methylase genes and one of which 
contains a GFP gene. The expected length of sequence from one methylase gene 
(methylase I) is 1074 bp while the sequence from the other methlylase gene (methylase 
II) is 874 bp. GFP sequence is expected to be 400 bp. Three 0.5 μL of each plasmid 
(approximately 50 ng) were added to 18.5 μL of PCR mixture containing 1×Taq buffer 
(Invitrogen, Grand Island, NY), 2.5 mM MgCl2 (Invitrogen), 0.2 mM dNTP mix 
(Invitrogen), 1 unit of Taq DNA polymerase (Invitrogen) and 0.2 μM of each pair of 
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primers. The multiplex PCR solution was aspirated into the PCR capillary by applying a 
vacuum to W on the six-port valve for 6.5 min. The PCR was performed using the 
following thermal cycling program: 5 min at 95 ℃, then 30 cycles of 30 s at 95 ℃, 30 s 
at 55 ℃, 30 s at 72 ℃ and 10 min at 72 ℃. After the PCR was finished, a vacuum was 
applied to W to pull the PCR products for 2 min into the cross section of the chip 
injector. The PCR reaction didn’t take place in the capillary section (~20 cm) between 
the chip and the thermocycler. According to the calculated velocity (~0.648 cm/s) of 
PCR products in the PCR capillary, it theoretically takes ~0.5 min for nearest PCR 
products to pass this capillary zone to arrive at the cross section. The calculated time 
range for all PCR products to reach the cross section is from ~0.5 to 4.5 min. A pressure 
of 40 psi was applied to the pressure chamber for 10 s (while PCR and waste capillaries 
were connected to the blocked positions on the six-port valve) to drive a plug of sample 
to BaNC-HDC column. Then, a pressure of 40 psi was applied to flush away the residue 
sample in the cross section for 10 s and ~1/1000 of normal injected volume of sample 
was expected to flow into the separation capillary in this step. For BaNC-HDC 
separation, ~200 psi was applied to the pressure chamber.  
 
The DNA template for amplifying actin was the genomic DNA of rice (Oryza 
sativa L.), cv Nipponbare. The amplified actin sequence is expected to be 405 bp. To 
prepare the PCR solution for amplification, 2 μL (approximately 50 ng) of genomic 
DNA was added to 18 μL of PCR mixture containing 1×Taq buffer (Invitrogen, Grand 
Island, NY), 2.5 mM MgCl2 (Invitrogen), 0.2 mM dNTP mix (Invitrogen), 1 unit of Taq 
DNA polymerase (Invitrogen) and 0.2 μM of primers. The same thermal cycling 
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program was used and all following steps were the same as described for the multiplex 
PCR in capillary. For BaNC-HDC separation, ~400 psi was applied to the pressure 
chamber. 
 
2.2.6 Performing multiplex PCR, on-line YOYO-1 intercalation, and BaNC-HDC 
separation 
After the apparatus was assembled as shown in Figure 2.2, ~4 nL of 7.0 µM 
YOYO-1 in 1× TE buffer (10.0 mM Tris-HCl and 1.0 mM EDTA at pH 8.0), and then 
~4 nL of 1× TE buffer were flushed through the BaNC-HDC column from the waste-
side under a pressure of ~350 psi. The system was initialized after a vacuum was 
applied to W on the six-port valve to clean the YOYO-1 in the chip injector. Step 1 
(Figure 2.2B): a multiplex PCR solution was first aspirated into the PCR capillary by 
applying a vacuum to W on the six-port valve while the valve was set at the “open” 
position. At this time, an ambient pressure or a pressure (~10 psi) slightly higher than 
the ambient pressure was applied to PC. Step 2 (Figure 2.2C): the valve was switched to 
the “closed” position, and thermal cycle reactions were performed. Step 3 (Figure 
2.2D): the valve was switched back to the “open” position while a vacuum was applied 
to W to pull the PCR products into the cross section of the chip injector. Step 4 (Figure 
2.2E): the valve was switched to the “closed” position, and a pre-determined pressure 
(e.g., 40 psi) was applied to PC for a given period of time (e.g., 10 s); a portion of the 
sample in the cross section was driven to the BaNC-HDC column. The amount of the 
injected sample was controlled by the pressure and the injection time. Step 5 (Figure 
2.2F): the valve was switched to the “open” position while a pressure (e.g., 40 psi) was 
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applied to PC; the residue sample in the cross section of the chip injector was flushed 
away from the inlet of the BaNC-HDC column. Step 6 (Figure 2.2G): the valve was 
switched to the “closed” position, and a pre-determined pressure (e.g., 200 psi) was 
applied to PC to effect BaNC-HDC separation.  
   
2.3 RESULTS AND DISCUSSION 
 
2.3.1 Characterization of on-line DNA–YOYO-1 intercalation 
For characterizing our approach for on-line DNA–YOYO-1 intercalation, we 
used an experimental setup that was reported previously (see Figure 2.1 for details). In 
one experiment, we used a bare capillary column and separated a 1-kbp-plus DNA 
ladder pre-intercalated with YOYO-1. The bottom-trace of Figure 2.3 presents the 
separation results. In a separate experiment, we charged YOYO-1 on the interior surface 
of the capillary column and separated the same DNA ladder but without YOYO-1 
intercalation. The top-trace of Figure 2.3 presents the separation results; all DNA 
fragments were nicely labeled and detected, and comparable resolutions and similar 
retention times were obtained. That is, we did not sacrifice any performance by using 
the on-line intercalation approach. 
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Figure 2.3 The comparison of on-line labelled method and prelablled method. The 
top trace shows the BaNC-HDC separation of on-line labelled DNA ladder (0.075, 
0.2, 0.3, 0.4, 0.5, 0.7, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 7.0, 10 and 20 kbp), while the bottom 
trace presents the separation of pre-labelled DNA ladder. The nanocapillary had a 
total length of 50 cm (40 cm effective) and a radius of 1 μm. The 1-kb-plus DNA 
ladder (total DNA 4 ng/μL) was injected at 40 psi for 10 s, and the separation was 
carried out at 350 psi. 
 
Importantly, we do not need to recharge YOYO-1 for every BaNC-HDC 
separation. Figure 2.4A presents a few typical traces (of the 1st, the 10th, the 20th, the 
27 
30th, and the 45th runs) as we injected the same sample repetitively after we charged 
the BaNC-HDC column once. Apparently, as the repetitive-injection test proceeded, the 
YOYO-1 storage on the capillary wall shrank. As a result, the number of YOYO-1 
molecules intercalated with each DNA fragment diminished, and consequently the 
fluorescence intensities decreased (Figure 2.4B). An excellent feature of this approach 
is that, although fluorescence intensities decreased gradually, the resolution, efficiency 
and retention time remained virtually unchanged (see Figure 2.5 for details). All DNA 
fragments could be positively identified and their sizes be accurately measured even 
after dozens of injections (e.g., see the inset of Figure 2.4A for an expanded view of the 
BaNC-HDC trace of the 45th run). 
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Figure 2.4 Repetitive run after single-time YOYO-1 charging. (A) Typical 
separation traces of DNA ladder (4 ng/μL total DNA). The inset presents an 
expanded view of the 45th run. (B) Peak areas varying with the number of 
repetitive runs. All separation conditions were the same as presented in Figure 2.3.  
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Figure 2.5 Resolution, efficiency and retention time varying with number of runs 
 
2.3.2 Incompatibility of YOYO-1 with PCR 
A Tandem repeat (microsatellite marker) was amplified using a PCR machine. 
The length is expected to be 300 bp. The template DNA was the genomic DNA of 
Bioethanol Saccharomyces cerevisiae strain BG-1 which was donated by Drs. 
Antonangelo and Colombi. Strains grew in 10 ml yeast peptone dextrose (YPD) 
medium for 12~16 h at 30 °C until A600 of culture reached to 0.6~0.8. Genomic DNA 
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of the yeast culture was extracted using Yeast Genomic DNA Purification Kit 
(AMRESCO, LLC, Solon, OH). 4 μL of genomic DNA (approximately 100 ng) was 
added to 46 μL of PCR mixture containing 1×Taq buffer (Invitrogen, Grand Island,NY), 
2.5 mM MgCl2 (Invitrogen), 0.2 mM dNTP mix (Invitrogen), 1.25 units of Taq DNA 
polymerase (Invitrogen) and 0.2 μM primers. The microsatellite marker was amplified 
using the following thermal cycling program: 5 min at 95 ℃, then 30 cycles of 30 s at 
95 ℃, 30 s at 55 ℃, 30s at 72 ℃ and 10 min at 72 ℃. Figure 2.6 presents the 
separation results. 
 
Figure 2.6 PCR of a tandem repeat (microsatellite marker) in Bioethanol 
Saccharomyces cerevisiae strain BG-1. (A) Slab gel electrophoresis result of PCR 
products from the PCR with or without YOYO-1. Lane1: 1kb plus DNA ladder. 
Lane2: PCR products without YOYO-1 as control. Lane3: 50 μL of the products 
when 0.1 nmol YOYO-1 was added in the PCR reactions (all other conditions were 
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the same as the control). 0.1 nmol of YOYO-1 was the amount adequate for 
labelling 500 ng DNA (at a dye:bp ratio of 1:10). Lane4: 50 μL of the products 
when 0.01 nmol YOYO-1 was added in the PCR reactions (all other conditions 
were the same as the control). 0.01 nmol of YOYO-1 was the amount adequate for 
labelling 50 ng DNA (at a dye:bp ratio of 1:10). (B) BaNC-HDC chromatograms of 
the same PCR products for (A). Top trace: 1-kb-plus DNA ladder; middle trace: 
PCR products without YOYO-1 as control; and bottom trace: products when 0.01 
nmol YOYO-1 was added in the PCR reactions. We also ran a BaNC-HDC 
separation for the products when 0.1 nmol YOYO-1 was added in the PCR 
reactions; the chromatogram (not shown) was similar to that of the bottom trace. 
 
2.3.3 Demonstration of integrating multiplex PCR, on-line injection, BaNC-HDC 
separation, and on-line DNA-YOYO-1 intercalation. 
To demonstrate the utility of this approach for practical uses, we assembled a 
system (Figure 2.1) that integrated a capillary PCR device, a microchip injector, and a 
BaNC-HDC column in a microfluidic format for multiplex PCR, on-line injection, 
BaNC-HDC separation, and on-line DNA-YOYO-1 intercalation. The resolved DNA 
bands were monitored via an LIF detector. Figure 2.7A presents the separation results 
of multiplex PCR products. The sizes of three products were estimated (see table 2.1 for 
details) to be 1.080, 0.895, and 0.398 kbp, in excellent agreement with their theoretical 
values (1.074, 0.874, and 0.400, respectively). Figure 2.7B presents the slab-gel 
separation results; the multiplex PCR was performed using a conventional Eppendorf 
tube and a MJ Research thermocycler. Figure 2.7C presents the separation of a segment 
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of a rice genomic DNA amplified in the PCR capillary. Because BaNC-HDC can 
tolerate large DNA template, the amplified fragment was on-line transferred to the 
BaNC-HDC column for separation. The BaNC-HDC separations were executed under 
~400 psi, and DNA–YOYO-1 intercalation was accomplished during the separation. 
The size of the fragment was measured to be 404 bp, compared to its theoretical value 
of 405 bp. Figure 2.7D presents the slab-gel separation result of the conventionally 
amplified product. 
 
 
34 
 
Figure 2.7 Performing multiplex PCR, BaNC-HDC separation, and on-line dye 
intercalation on an integrated microfluidic platform. (A) BaNC-HDC separation 
traces. The top trace was obtained from separating 1-kbp-plus DNA ladder, and 
the bottom trace was obtained from separating the multiplex PCR products 
amplified in the capillary thermocycler (30 cycles, see Capillary PCR in SI for 
details). The BaNC-HDC separations were executed under ~200 psi. (B) Slab-gel 
electrophoresis of the crude multiplex PCR products amplified by a MJ Research 
thermocycler (30 cycles). Lane 1 – DNA ladder; Lane 2 – crude PCR multiplex 
products. (C) BaNC-HDC separation of a PCR-amplified genomic region (30 
cycles, see Capillary PCR in SI for details). The top trace represents the separation 
of a 1-kbp-plus DNA ladder, and the bottom trace is the result of the separation of 
an actin sequence from a rice genomic DNA that was amplified by the capillary 
PCR and on-line intercalated with YOYO-1. The BaNC-HDC separations were 
executed under ~400 psi. Other conditions were similar to (A). (D) Slab-gel 
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electrophoresis of conventional PCR-amplified actin sequence. Lane 1 – DNA 
ladder, and Lane 2 – actin. Other conditions were similar to (B). 
 
2.3.4 Calculation of the three multiplex products length 
To validate the method for measuring the lengths of DNA fragments, we use the 
top chromatogram in Fig. 2.7A to establish a relationship between the relative mobility 
of a DNA and its length based on an HDC quadratic model as we described previously49. 
Relative mobility was defined as the ratio of the velocity of a DNA fragment to the 
average velocity of the eluent. The fragment velocity was calculated by dividing the 
effective capillary length by its retention time, while the eluent velocity was obtained by 
measuring its flow rate and dividing the measured flow rate by the narrow capillary 
cross-section area. As presented in Figure 2.8, the curve-fitting generated an excellent 
correlation coefficient (R2 = 0.9999) for equation (1). 
Y  = 1 + 2 ∗  117.9 ∗
L 
 .   
R
  −  117.9 ∗
L 
 .   
R
 
 
− 0.06516 ∗ L            (1) 
Yi is the relative mobility of DNA fragment i (Yi=vi/v0, where vi and v0 are the transport 
velocities of DNA fragment i and the eluent), Li is the length of the fragment in kbp, 
and R (1000nm) is the radius of the narrow capillary. Yi values for the fragments in all 
repetitively injected samples were measured and substituted into Equation 1, and Li was 
computed. These results are listed in Table 2.1; excellent length accuracies were 
obtained. 
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Figure 2.8 Curve-fitting results between DNA relative mobility and fragment 
length. All data were obtained from Figure 2.7A.  
 
Table 2.1 DNA length (kbp) of multiplex PCR products 
Theoretical calculated 
values 
Measured experimental 
values (Li) 
1.074 1.080±0.005 
0.874 0.895±0.004 
0.400 0.398±0.002 
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2.4 Conclusions 
We have developed an innovative and simple approach for on-line intercalation 
of YOYO-1 with DNA. The method consumed only ~4 nL YOYO-1 solution to charge 
the BaNC-HDC column, and the YOYO-1 adsorbed on the capillary wall allows for 
dozens of BaNC-HDC runs without recharging. Taking advantage of an excellent 
feature of BaNC-HDC for tolerating high salt contents, large DNA templates, and big 
enzyme molecules required for PCR, we have integrated a capillary PCR with BaNC-
HDC and this on-line intercalation approach onto a microfluidic platform. We finally 
demonstrated the feasibility of using this platform for multiplexed PCR, on-line 
intercalation of the amplified products, BaNC-HDC separation, and LIF detection. With 
the advancement of microfluidic and nanofluidic devices for bioanalysis, single-DNA 
molecules have been entrapped in nanopores for enzyme digestions50, microfluidic 
chips have been developed for PCR51, 52, and a miniaturized LIF detector53 has also been 
constructed for detection on microfluidic chips. The reported microfluidic platform, 
combining with the above technologies, holds great promises for point-of-care 
applications. 
 
 
The material in chapter 2 is adapted from Chen, H., Zhu, Z., Lu, J. J., Liu, S., Analytical 
chemistry 2015, 87 (3), 1518-1522. The copyright permission is obtained from ACS.  
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Chapter 3: Simple means for fractionating protein based on isoelectric 
point without ampholyte 
 
3.1 Introduction 
Biological samples are usually too complex for analyzing all directly. 
Fractionation or prefractionation is a technique commonly used to reduce sample 
complexities before analysis in proteomic research54-56. Protein fractionation based on 
isoelectric focusing (IEF) is a great example57-60, and several commercial instruments 
are constructed to take advantage of this principle.  
Rotofor® is such an electrophoretic instrument manufactured by Bio-Rad 
(Hercules, CA). The system has 20 sample chambers separated by liquid permeable 
nylon screens with cation and anion exchange compartments at its extremities. At the 
end of IEF with conventional carrier ampholytes, proteins focused in their 
corresponding isoelectric point (pI) zones can be collected for further analysis 
(www.bio-rad.com).  
Proteome™ Lab (PF-2D) is a two-dimensional protein fractionation platform 
launched by Backman Coulter (Indianapolis, IN) for mapping protein profiles. The 
platform utilizes high performance liquid chromatography (HPLC) as a basis for two-
dimensional separation of proteins in a liquid phase in an automated format 
(www.beckmancoulter.com). The outcome of the fractionation is the generation of a 
protein map based on pI and hydrophobicity. The gel-free liquid nature of the system 
allows for isolation of the proteins of interest in their native, intact states that can be 
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further analyzed using conventional techniques (e.g., ELISA, Western blot, or mass 
spectrometry).  
OFFGEL is an apparatus developed by Agilent Technologies (www.agilent.com) 
for fractionating proteins/peptides in liquid phase. A sample is placed in a liquid 
chamber, and the solution is positioned on top of an immobilized pH gradient (IPG) gel 
and allowed to be in direct contact with the gel. Several such liquid chambers can be 
arranged in a row along the IPG gel. The gel buffers a thin layer of the solution in each 
liquid chamber and the proteins are charged according to their pI and the pH imposed 
by the gel. Upon application of an electric field perpendicularly to the liquid chambers, 
the electric field penetrates into every chamber and extracts charged species into the gel. 
After separation, only the neutrally charged species remain in chamber solutions61-64. 
Other approaches have been explored, but their practical uses are not as 
successful as the above mentioned devices. A multicompartment electrolyzer (MCE) 
was built by Proteome Systems, Inc. (Woburn, MA). [Note: Proteome Systems went out 
of business in 2008.] MCE is similar to Rotofor®, but it is compartmentalized by 
immobilized pH membranes that do not allow free exchange of solution between 
chambers65. A free-flow electrophoresis (FFE) system was developed by Becton 
Dickinson (Franklin Lakes, NJ) to fractionate proteins for preparative purification. 
However, Becton Dickinson has announced to exit the FFE business (www.bd.com) 
because they concluded that the sales outlook for FFE did not justify the ongoing 
investment in the product platform. PBE-94 resin has been used as an anion exchanger 
to fractionate complex protein samples.5 When a protein sample and the resin is mixed 
in a solution at an given pH, negatively charged proteins bind to the resin while 
40 
neutrally and positively charged proteins remain free in the solution. Centrifugation is 
then utilized to collect the negatively charged proteins. An online multiple-junction 
capillary isoelectric focusing fractionator (OMJ-CIEF) was recently introduced66. In 
OMJ-CIEF, the separation capillary is segmented into seven equal sections, and 
adjacent sections are joined via tubular Nafion membrane insertions. Each junction is 
immersed in an external buffer to manipulate the pH of the solution inside the capillary. 
By applying a voltage across the capillary, proteins are focused in particular capillary 
segments according to their pI values.  
Here we introduce a simple alternative means to fractionate proteins in liquid 
phase. Referring to Figure 3.1, we first adjust the pH of a protein sample to pH1. 
Depending on pH1 and protein pI values, some proteins are positively charged, some 
are negatively charged, while some are neutral. We then introduce the sample into an 
acrylamide-coated capillary, and dip the capillary ends into an anode reservoir 
containing a buffer (B1) with a pH=pH1-ΔpH and a cathode reservoir containing a 
buffer (B2) with a pH=pH+ΔpH. As an electric field is applied across the capillary, 
positively charged proteins move to cathode reservoir, negatively charged proteins 
migrate to anode reservoir, while neutral proteins [with (pH1-ΔpH)<pI<(pH1+ΔpH)] 
remain inside the capillary. The sample is separated into three fractions, and the sample 
complexity is thus reduced. This step is considered to be the 1st-level (L1, see Figure 
3.1B) fractionation. We then adjust the pH of the solution from the anode reservoir to 
pH2 [pH2< (pH1-ΔpH)] and the pH of the solution from the cathode reservoir to pH3 
[pH3> (pH1+ΔpH)] to perform the 2nd-level fractionations. (Note: as long as the value 
of ΔpH is small, the solution inside the separation capillary does not need to be 
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fractionated.) At the end of the 2nd-level separations, the original sample is fractionated 
into 7 fractions (1 from the separation capillary in the 1st-level fractionation, and 6 from 
the 2nd-level fractionations). The complexities of the resultant fractions are therefore 
further reduced. These operations can be repeated as desired. The number of fractions at 
the end of the nth-level separation equals (n2+5n)/2. In this work, we explore the 
feasibility of this approach. Since no pH gradient is needed, we eliminate ampholytes 
which interfere with MS analysis of the fractionated samples67-69. 
 
 
Figure 3.1 Schematic representation of electrokinetic fractionation working 
principle. A. Schematic arrangement of experimental setup. S: sample buffered at 
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pH1, B1: buffer solution with a pH of pH1-pH, and B2: buffer solution with a pH 
of pH1+pH. B. Schematic representation of electrokinetic fractionation principle. 
L1 (level 1): original sample being separated into three fractions; L2 (level 2): 
collection reservoir solutions being further separated; and so on. 
 
3.2 Experimental section 
 
3.2.1 Reagents and Materials 
Acrylamide, N,N ′ -ethylenebisacrylamide (bis, a cross-linker), (3-
methacryloxypropyl)-trimethoxysilane (a bifunctional reagent), N,N,N ′ ,N ′ -
tetramethylethylenediamine (TEMED), Benzonase, ammonium persulfate (APS), α-
cyano-4-hydroxycinnamic acid (CHCA), 2,5-dihydroxybenzoic acid (DHB), 
ribonuclease A (pI 9.6), amyloglucosidase  (pI 3.6), myoglobin (pI 6.8 and 7.2), 
trypsinogen (pI 9.3), carbonic anhydrase from bovine (pI 5.9), carbonic anhydrase from 
human (pI 6.6), bovine serum albumin (BSA, pI 4.9) and trypsin inhibitor (pI 4.6) were 
all purchased from Sigma (St. Louis, MO). Fused silica capillaries were purchased from 
Polymicro Technologies (Phoenix, AZ) and Teflon tubing was purchased from Cole-
Parmer Instrument (Vernon Hills, IL). All solutions were prepared with double-
deionized (DDI) water purified by a NANOpure infinity ultrapure water system 
(Barnstead, Newton, WA). Dialysis membrane (MWCO: 3.5-5 kD and 100-500 D) was 
purchased from Spectrum Laboratories (Rancho Dominguez, CA). OmniPur Coomassie 
Blue G-250 was bought from EMD (Gibbstown, NJ). 
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3.2.2 Capillary coating 
The coating protocol is modified based on a method70, 71. Briefly, a 100 cm long 
capillary with 360 μm outer diameter (o.d.) and a 150 μm inner diameter (i.d.) was 
filled with a 1.0 M NaOH solution and kept at 100 ℃ for 2 h with two ends sealed to 
activate the inner surface. It was then flushed with 1.0 M HCl for 1 h, DDI water for 0.5 
h, and acetonitrile for 12 min. After being dried with helium, the inner surface of the 
capillary was reacted with a 30% 3-(Trimethoxysilyl)propyl methacrylate in acetonitrile 
for 19 h at 50 ℃, rinsed with acetonitrile for 10 min, and dried with helium. The 
capillary was then flushed with a degassed solution containing 3%T (the total weight 
concentration of acrylamide and bis in the solution) and 0.6%C (the concentration of bis 
relative to the total of acrylamide and bis), 0.05% (v/v) TEMED, and 0.075% APS for 5 
min in an ice bath, another degassed solution containing 12%T and 0.6%C for 6 min, 
and then dried with helium. The capillary was cut into desired length for pI based 
fractionation.    
 
 
3.2.3 Bradford assay 
Bradford assay was used to determine protein concentrations in fractionated 
solutions for recovery evaluations. Bradford reagent was prepared by dissolving 5 mg 
Coomassie Blue G-250 in 2.5 mL 95% ethanol, 5 mL 85% phosphoric acid, and some 
DDI water. The solution was then transferred to a 50-mL flask, and filled with DDI 
water to mark. Calibration curve was established using BSA as a standard at different 
concentrations (0, 0.15, 0.30, 0.45 and 0.60 mg/mL). For concentration determination, 4 
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μL of a sample or standard was mixed with 400 μL of Bradford reagent, and its 
absorbance was measured at 595 nm.    
 
3.2.4 Sodium dodecylsulfate – polyacrylamide gel electrophoresis (SDS-PAGE) of 
fractionated sample 
SDS-PAGE was performed by mixing ~8 μL sample with 2 μL 5× sample buffer 
(0.5 M Tris-HCl pH 6.8, 10% SDS, 30% glycerol, 5% beta-mercaptoethanol, 0.05% 
bromophenolblue) and cooked in a boiling water bath for 5 min before electrophoresis. 
A Bio-Rad Mini-PROTEAN Tetra Cell system was used for running the SDS−PAGE. 
The separating gel contained 11.7% acrylamide and 0.3% bis, while the stacking gel 
contained 3.9% acrylamide and 0.1% bis. Gels were polymerized between two glass 
plates in a gel caster, with a 15-well comb inserted at the top to create sample wells. 
After the gel was polymerized, the comb was removed and the gel was ready for 
electrophoresis. A running buffer was prepared by adding 3.03 g Tris, 12.01 g glycine, 
and 1.00 g SDS in 1.00 L DDI water. A constant voltage (200 V) mode was used for the 
separation. The separation was stopped when the sample front moved ~0.5 cm to the 
end of the gel; usually the electrophoresis time was 50 min. The gel was then taken out, 
and silver stained for visualization of the protein bands. 
 
3.2.5 Preparation of soluble protein extract from Hela cell 
HeLa cells were cultured in Dulbecco’s Modified Eagle’s medium (Invitrogen, 
Green Island, NY) supplemented with 10% fetal bovine serum (FBS), penicillin (100 
units/mL) and streptomycin (100 ug/mL). Approximately 6*107 cells were harvested 
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and then washed with PBS three times at 1000 rpm for 5 min each time. Cells 
suspended in 1 mL PBS were sonicated at 30% power output and 20% duty cycle using 
a Branson Sonifier 450 for four rounds; 5 s sonication for each round. The mixture was 
then centrifuged at 13000 rpm for 10 min to remove solid debris. 0.5 μL Benzonase and 
5 mM MgCl2 were added into the resultant supernatant to digest DNA and RNA at 
room temperature for 1 h. An Amicon Ultra-0.5 centrifugal filter device from Sigma 
was used to desalt the DNA-digested sample. The proteins were collected by spinning 
off from upside-down filter device at 1,000 × g, and then re-dissolved in DDI water. 
 
3.2.6 Preparation of protein complex from Hela cell mitochondria 
Approximately 6*107 cells were harvested and then washed with PBS three times 
at 1000 rpm for 5 min each time after trypsinization. Cells suspended in PBS were 
broken by sonication as described in the manuscript text. All cell debris and nuclei were 
removed by centrifugation at 1000 x g for 10 min at 4 °C. Mitochondria was collected 
from the supernatant by centrifuging at 12,000 x g for 20 min at 4 °C and washed once 
with PBS buffer. The obtained mitochondrial pellets can be stored at -80 °C for future 
use or suspended by adding 250 μL of sample buffer containing 1 % w/v lauryl 
maltoside, 250 mM sucrose, 10 mM HEPES, and 1 mM EDTA (pH 7.0) for immediate 
use. The sample was layered on the top of a stepwise density gradient of sucrose, which 
was prepared by orderly adding 300 μL each of 43, 40, 37.5, 35, 32.5, 30, 27.5, 25, 22.5, 
20, 17.5, 15, 10 % in 10 mM HEPES and 0.05 % w/v lauryl maltoside pH 7.0 onto an 
Ultra-ClearTM centrifuge tube (Beckman Coulter, Inc., CA). The ultracentrifugation 
proceeded for 20 h at 40000 rpm in the MLS-50 swing-bucket rotor of Beckman 
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OptimaTM MAX-XP machine (Beckman Coulter, Inc.). The protein complex from 
mitochondria was aspirated out from centrifuge tube.   
 
3.2.7 Two-dimensional electrophoresis (2DE) of fractionated sample 
A Protein i12 IEF system and Criterion Vertical Electrophoresis Cell both from 
Bio-Rad were employed for 2DE. 16 μL of fractionated sample was mixed with 190 μL 
Bio-Rad ReadyPrep Rehydration/Sample Buffer (8 M urea, 2% CHAPS, 50 mM 
dithiothreitol, 0.2% (w/v) Bio-lyte 3/10 ampholytes, and bromophenol blue (trace)). A 
Bio-Rad 11-cm, pH 3–10, immobilized pH gradient (IPG) strip was rehydrated with 206 
μL sample solution at room temperature for 16 h. After rehydration, the Bio-Rad 11cm, 
pH 3-10 R protocol stored in Protein i12 IEF system was used for focusing. After 
focusing, the IPG strip was transferred onto a Bio-Rad 4–20%, 11-cm precast gel for the 
second dimension separation. Gels were silver stained for visualization of the protein 
bands. 
 
3.2.8 Apparatus 
Figure 3.2A presents the apparatus configuration of the anode-side; the cathode-
side is identical to the anode-side but the anode is replaced by a cathode. The separation 
capillary had a length of 45 cm, an o.d of 360 µm and an i.d. of 150 µm. The anode 
collection reservoir had a volume of 600 μL, and the anode reservoir had a volume of 
100 mL. The teflon tubing had a length of 22 cm, an o.d. of 1.05 mm, and an i.d. of 0.55 
mm. A dialysis membrane interface (DMI) was utilized to facilitate the application of 
an electric field across the separation capillary. Construction of the DMI is presented in 
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Figure 3.2B. A 10-µL pipette tip was cut (so that it could put inside the anode collection 
reservoir properly), its smaller end was wrapped with a dialysis membrane (DM), and 
the DM was fixed in position and sealed with a parafilm tape. 
 
Figure 3.2 Apparatus for electrokinetic fractionation. A. Apparatus configuration 
of the anode-side. The apparatus on the cathode-side is image-symmetric to that on 
the anode-side. DM: dialysis membrane; DMI: dialysis membrane interface; 
Separation capillary: 45 cm coated capillary with an o.d of 360 µm and an i.d. of 
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150 µm; Teflon tubing: 22 cm with an o.d. of 1.05 mm, and an i.d. of 0.55 mm; 
Anode/cathode reservoir: 100 mL container; Anode/cathode collection reservoir: 
600 μL tube. B. Preparation of DMI. 
 
3.2.9 Electrokinetic fractionation 
After the pH of 10 mM ammonium acetate buffer was adjusted to pH1, sample 
proteins were dissolved with this buffer. B1 was prepared by adding a small amount of 
acetic acid (HAc) while B2 was prepared by adding a small amount of ammonia 
(NH4OH). The pH of B1 and B2 were then measured. The teflon tubing and the DMI on 
the anode side, and the anode reservoir were filled with B1, while the anode collection 
reservoir was loaded with 8.5 μL B1. The teflon tubing and the DMI on the cathode side, 
and the cathode reservoir were filled with B2, while the cathode collection reservoir was 
loaded with 8.5 μL B2. After the separation capillary was filled with a sample (~8 μL), 
20 kV was applied between the cathode and anode for electrophoresis. The 
electrophoretic separation was allowed to proceed for a given period of time (usually 50 
min unless otherwise indicated), the solutions from the anode and cathode collection 
reservoirs and the separation capillary were harvested for further analyses.  
To perform the next-level fractionation, the pH of a new sample was adjusted to a 
different value (e.g., pHi), buffers with pH=pHi-ΔpH and pH=pHi+ΔpH were prepared, 
and the same procedure was followed for electrokinetic separations. 
 
3.3 Results and Discussion 
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3.3.1 Suppression of electroosmotic flow (EOF) 
Suppression of the EOF inside the separation capillary is key to the success of our 
fractionation approach. Otherwise, the sample will be moved out to a collection 
reservoir during electrokinetic separations. In this experiment, a coated capillary usually 
had a μeo of less than 1×10-10m2V-1s-1. Under the experimental conditions (20 kV across 
a 45 cm separation capillary), the solution inside the separation capillary should not 
move more than 13 mm for a 50 min run. 
 
3.3.2 Effect of Pharmalyte on MS signal 
To examine the effect of additives on MS signal, we mixed Pharmalyte at various 
concentrations with Trypsinogen, and loaded this solution (~0.5 µL per spot) directly 
onto a MALDI-MS target plate. After the solvent was dried, we added 0.5 µL of 
MALDI-MS matrix, a 1:1 mixture of solution A and solution B (A: 20 mg/mL α-cyano-
4-hydroxycinnamic acid, 50% ACN and 50% Methanol; B: 30% ACN and 0.1% 
Trifluoroacetic acid) to each sample spot and allowed the sample to evaporate again. 
Figure 2s exhibits the effect of Pharmalyte on the MS signal. Figure 3.3B, 3.3C and 
3.3D show that Pharmalyte severely suppressed the MS signal. At 3.6% Pharmalyte, no 
MS signal could be detected. Even at 0.9% Pharmalyte, the MS signal was reduced by 
17 fold relative to the MS signal of the protein in 10 mM ammonium acetate buffer. 
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Figure 3.3 Effect of Pharmalyte on MS signal. The sample contained 0.2µg/µL 
Trypsinogen and various concentrations of Pharmalyte. 0.5 µL of this sample was 
loaded a MALDI target plate. After the sample was dried, 0.5 µL of a matrix 
solution was added to the sample spot. Then the matrix solvent was evaporated 
and the target plate was loaded into an Applied Biosystems 4800 Proteomics 
Analyzer. The MS spectra were measured at an m/z range of 15 kDa- 30 kDa with 
a focus m/z of 24 kDa in a linear mode. Spectra in Figures B, C and D were 
obtained from the protein-Pharmalyte mixtures, while spectra in Figures A were 
obtained from the protein in 10 mM ammonium acetate buffer. 
 
3.3.3 DMI 
The use of DMI is necessary because (1) putting a metal electrode directly in a 
collection reservoir will oxidize/reduce the proteins and (2) electrolysis will change the 
51 
pH of the solution inside the reservoir. This issue can be serious if a small volume of 
solution will be used in the reservoir. By using a DMI, we can employ a large-volume 
container (e.g., 100 mL) as an anode or cathode reservoir. Since electrolysis will occur 
only in the anode or cathode reservoir, proteins in the collection reservoir will not be 
oxidized/reduced, and the electrolysis-generated H+ or OH- will be effectively buffered 
by the large-volume buffer solution. 
 
3.3.4 pH variation in collection reservoir 
Electrolysis can still cause the pH variations of the solution inside a collection 
reservoir owing to the blockages of charged proteins by the DM. Let us take the anode 
collection reservoir (see Figure 3.2A) as an example to explain this effect. During 
electrophoresis, the electric current will be carried by all electrolytes including 
negatively-charged proteins. If a negatively-charged protein is blocked by the DM, 
some other anions (a portion of it will be OH-) will have to move from the collection 
reservoir across the DM to the DMI solution or/and some other cations (a portion of it 
will be H+) will have to move across the DM in the opposite direction in order to 
maintain the solution neutrality. As H+/OH- leaves/enters the collection reservoir, its pH 
will decrease. Similarly, when a positively charged protein is blocked by the DM inside 
the cathode collection reservoir during electrophoresis, some H+/OH- will leave/enter 
the reservoir, its pH will increase.  
 
The pH changes due to the above effect can be alleviated effectively by adding 
some electrolyte (e.g., NaCl) in the buffer. [Note: the electrolyte should not be added in 
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the sample solution.] The increased electrolyte concentration will reduce the probability 
of H+/OH- as current carriers and hence suppress the pH variations. 
 
3.3.5 Protein recovery 
If a DMI was not properly constructed (e.g., the DM was not tightened well to the 
pipette tip or it was broken), proteins would migrate across the DM to the DMI 
solutions and be lost. To examine whether proteins were lost, we measured the recovery 
rate of our fractionation method. We first prepared three 0.2 mg/mL protein (BSA, 
myoglobin or trypsinogen) standard solutions in 10 mM ammonium acetate at pH=7.0. 
These samples were then electrokinetically fractionated at pH1=7.0 with a ΔpH between 
0.4~0.5. At the end of each separation (50~60 min), BSA migrated into the anode 
collection reservoir, trypsinogen migrated into the cathode collection reservoir, and 
myoglobin remained in the separation capillary. Protein quantities in these solutions 
were determined via Bradford method. The ratio of measured value to the theoretical 
value was recorded as the recovery rate. Recovery rates between 93-97% were obtained. 
We also fractionated a sample containing all three proteins, similar recovery rate were 
obtained. This indicated that most proteins were constrained in the two collection 
reservoirs and the separation capillary. 
 
3.3.6 Electrophoresis time 
Electrophoresis time was an important parameter for our method. If too short, 
proteins would not have time to migrate to their equilibrated positions. If too long, time 
was wasted. To determine the optimum electrophoresis time, we prepared a standard 
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solution containing 8 proteins and electrokinetically fractionated the sample at 
pH1=6.65 with a ΔpH of ~0.1 under different electrophoresis times. The results are 
presented in Figure 3. At an electrophoresis time of 30 min, some trypsinogen (pI 9.3) 
still remained inside the separation capillary. An electrophoresis time of 50 min or 
longer, protein migration equilibria seemed to have been reached because the band 
patterns/intensities in the 50-min and 70-min boxes looked very similar. In this work, 
50-min electrophoresis time was selected to run all electrokinetic fractionations under 
the captioned experimental conditions. 
     
Figure 3.4 Effect of electrophoresis time on separation. Electrokinetic 
fractionation was performed at pH1=6.65 with a ΔpH of ~0.1 and a voltage of 20 
kV under different electrophoresis times. SDS-PAGE was carried out on a Bio-
Rad Mini-PROTEAN Tetra Cell system using a 0.75 mm separating gel (11.7% 
acrylamide and 0.3% bis) and stacking gel (3.9% acrylamide and 0.1% bis) at 200 
V. Gels were silver stained for visualization of the protein bands. The 
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electrophoresis time of each test was placed on top of each dashed box. Lane S: 
original sample; Lane C: fraction from separation capillary; Lane +: fraction from 
anode collection reservoir; Lane -: fraction from cathode collection reservoir; 
Lane M: molecular weight marker. The number above each protein band 
represents the PI of the protein. Sample: mixture of eight proteins [ribonuclease A 
(pI 9.6), amyloglucosidase (pI 3.6), myoglobin (pI 6.8 and 7.2), trypsinogen (pI 9.3), 
bovine carbonic anhydrase (pI 5.9), human carbonic anhydrase (pI 6.6), bovine 
serum albumin (BSA, pI 4.9) and Trypsin inhibitor (pI 4.6)] at a concentration of 
0.2 mg each/mL. 
 
3.3.7 Multi-level fractionation 
To demonstrate feasibility of running multi-level fractionation, we used the same 
eight-protein sample and performed the 2nd-level and the 3rd-level (partial) 
fractionation. The results are presented in Figure 3.5. All eight proteins were effectively 
separated and fractionated. 
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Figure 3.5 Multi-level fractionation. Eight proteins were initially (L1) fractionated 
at pH 6.65; this separation results in three fractions S1, S2 and S3. S2 and S2 are 
then (L2) fractionated at pH 4.91 and 9.32, resulting in S4, S5 and S6, and S7, S8 
and S9, respectively. S5 is further (L3) fractionated at pH 4.31 resulting in S10, 
S11 and S12. In all tests, ΔpH was ~0.1. The symbol on top of each box stands for 
the sample before that fractionation, the symbol in each parenthesis indicates the 
level of fractionation, and the symbols underneath each box represent the samples 
after that fractionation. The pH at the top but inside each box indicates the sample 
solution pH for running that fractionation. Electrokinetic fractionation and SDS-
PAGE conditions, the meanings of other symbols are the same as presented in 
Figure 3.4. 
 
56 
3.3.8 Fractionation of Hela cell protein extract 
To demonstrate feasibility of fractionating real-world samples, we prepared a 
protein sample from Hela cells. The sample was fractionated at pH1=7.0 with a ΔpH of 
~0.5. The 2DE separation results of solutions from anode collection reservoir, 
separation capillary and cathode collection reservoir were respectively presented in 
Figures 3.6A, 3.6B and 3.6C. When these three figures were combined together, a full 
2DE image of the sample was synthesized (see Figure 3.6D). To examine where 
proteins were lost during the fractionation process, we ran a 2DE separation of the 
original sample. Figure 3.6E presents the results. The similarity between Figures 3.6D 
and 3.6E indicates few proteins were lost. 
  
Figure 3.6 2DE results of soluble Hela cell proteins. IEF was performed using a 
Bio-Rad 11cm-pH 3-10 IPG strip. After focusing, the IPG strip was transferred 
onto a Bio-Rad 4–20%, 11 cm precast gel on a Bio-Rad Protein i12 IEF system for 
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the second dimension separation. Running voltage was 200 V. Gels were silver 
stained for visualization of the proteins. Electrokinetic fractionation was carried as 
described in Figure 3.4 with sample pH of 6.78 and a electrophoresis time of 50 
min. (A), (B) and (C) show the 2DE results of fractions collected from cathode 
collection reservoir, separation capillary and anode collection reservoir; (E) is an 
overlaid image of (A), (B) and (C); (D) is the 2DE image of the original sample as a 
control. 
 
3.3.9 MALDI-TOF-MS analysis of fractionated protein 
A commercial MALDI-TOF-MS (model 4800 plus, AB Sciex, Darmstadt, 
Germany) was used for mass analysis of fractionated protein complex sample. 
Positively charged ions were analyzed in the linear mode. Two basic matrixes (matrix A 
containing 10 mg/mL CHCA in 70 % v/v acetonitrile-water with 5 % v/v formic acid; 
Matrix B containing 10 mg/mL DHB in 70 % v/v acetonitrile-water with 0.05 % v/v 
trifluoroacetic acid) were 1:1 mixed right before use. The above mixture was then 
mixed with a sample at a 1:1 ratio. The sample-matrix mixture was then loaded onto a 
metal target plate. Mass spectra of intact proteins was obtained by averaging 1000 
random laser shots on each sample spot as shown in Fig.3.7. 
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Figure 3.7 MALDI-TOF MS of Intact proteins from fractionated mitochondrial 
complexes. 
 
3.4 Conclusion 
We have developed a simple electrokinetic means to fractionate protein samples 
according to their pI values and demonstrated the feasibility of using this approach for 
fractionating real-world samples. The method does not require sophisticated equipment, 
and its consumable costs are low. More importantly, the fractionated sample are MS-
friendly because we eliminate the use of ampholytes that interfere with MS analysis 
(see Figure 3.3). Figure 3.7 presents an example of a MS spectrum for a sample 
fractionated by this method. The method will be an excellent way to purify a specific 
protein (e.g., an antibody) for analytical and micropreparative purposes. The method is 
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fast compared to some other approaches (e.g., OFFGEL), but its sample throughput is 
low. We have an on-going project for implementing this approach on a microfabricated 
device. Duplicated structures will be arranged on the device to perform multiple 
electrokinetic fractionations in parallel, which will increase the sample throughput 
dramatically. Nevertheless, because of its simplicity and low cost, the method will be an 
outstanding choice for research labs with limited resources. 
 
 
The material in chapter 3 is adapted from Chen, H., Zhu, Z., Yu, H., Lu, J. J., Liu, S., 
Analytical Chemistry 2016, 88 (18), 9293-9299. The copyright permission is obtained 
from ACS. 
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Chapter 4:  Two-dimensional chromatographic analysis using three 
second-dimension columns for continuous comprehensive analysis of 
intact proteins 
 
4.1 Introduction  
In proteomic research, two complementary approaches (bottom-up and top-down) 
are commonly used for protein analysis. The bottom-up approach has progressed 
rapidly due to the advancement of modern mass spectrometry (MS), enabling 
identification and quantitation of hundreds or even thousands of proteins in single 
analysis72-75. However, this approach can miss the information of post-transitional 
modification, mutations and proteolytic cleavage, and therefore other approaches are 
constantly sought76-78. The top-down approach is a great alternative, in which intact 
proteins are individually analyzed. One of the most challenging tasks in the latter 
approach is to isolate proteins from a background of many other proteins and complex 
matrices. Often, this is beyond the resolving power of a one-dimensional separation 
technique. Vast effort has been invested on exploiting multi-dimensional separation 
strategies and progress has been made recently79, 80. 
Two-dimensional electrophoresis (2DE) is a powerful method for separating 
intact proteins. It quickly became routine after its introduction in 197581. However, 
extracting individual proteins after 2DE separation is tedious and time-consuming. In 
the last decade or so, two-dimensional (2D) high performance liquid chromatography 
(HPLC) has received considerable attention due to its attractive features82-84 such as 
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great number of column (or HPLC mode) choices, high resolving power, convenience 
for collecting resolved-proteins, straightforwardness for automating 2D HPLC, etc. 
While some 2D HPLC techniques85-87analyze portions of the first dimension 
(first-D) effluents, a comprehensive 2D HPLC analyzes all of them, preventing losses of 
any proteins. One of the early comprehensive 2D HPLC systems was constructed by 
Bushey and Jorgenson25. Through an eight-port valve, these authors coupled cation 
exchange and size exclusion chromatography for intact protein separations. Carr’s 
group1124, 88, 89, is also an active team on developing comprehensive 2D HPLC, 
especially on the high-speed 2D HPLC. More recent advances in 2D HPLC have been 
reviewed by Hanash90, Carr91, and Stoll92. 
A major challenge in current 2D HPLC is the limited separation speed in the 
second dimension (second-D). Because current 2D HPLC systems employ one first-D 
column and one second-D column, and the first-D effluent is fractionated and 
sequentially analyzed by the second-D. In order to retain the first-D resolution, one has 
to fractionate its effluent frequently (or in small segments) to minimize the re-mixing of 
the resolved analytes. Unless the effluent fractions are parked somewhere for later or 
off-line analyses, the second-D separation has to be fast in order for all the first-D 
fractions to be analyzed in time. The use of multiple parallel columns at the second-D 
can be a solution to this problem.  
In this work, we develop an innovative approach to overcome this problem. We 
incorporate multiple columns in the second-D to enable several second-D separations to 
be performed in parallel. That is, while the effluent of the first-D is loaded into one of 
the second-D columns, separations in other second-D columns are preceded 
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simultaneously. By doing so, we reduce the speed requirement of the second-D 
separation by a factor of n, where n is the number of the second-D columns. To 
demonstrate the feasibility of this approach, here we construct a 2D HPLC with three 
second-D columns and show the results of using this system for analyzing both proteins 
standards and E. Coli lysates. 
 
4.2 Experimental section 
 
4.2.1 Reagents and Materials 
Fused-silica capillaries were products of Polymicro Technologies Inc. (Phoenix, 
AZ). Tetrahydrofuran, 1-propanol, 1,4-butanediol, 1-decanol, 2,2’-
azobisisobutyronitrile (AIBN, 98%), and protein standards were obtained from Sigma 
(St. Louis, MO). Hydrochloric acid, sodium chloride, sodium hydroxide, tris(hydroxyl-
methyl)aminomethane (Tris), and ethylenediamine- tetraacetic acid (EDTA) were 
obtained from Fisher Scientific (Fisher, PA). Ethylene glycol dimethacrylate (EDMA, 
98%), glycidyl methacrylate (GMA, 97%), styrene (99%), divinylbenzene (80%), and 
diethylamine were purchased from Alfa Aesar (Ward Hill, MA). Methanol, acetonitrile, 
and tetrafluoric acid were products of EMD Chemicals, Inc. (Gibbstown, NJ). 
Methacryloyloxypropyltrimethoxysilane (γ-MAPS, 98%) was purchased from Acros 
(Fairlawn, NJ). All solutions were prepared with ultrapure water purified by a NANO 
pure infinity ultrapure water system (Barnstead, Newton, WA). 
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4.2.2 Preparation of Reverse-Phase (RP)-HPLC Monolith  
The inner wall of a capillary (120 cm length × 250 μm i.d. × 360 μm o.d.) was 
vinylized following the procedures we reported previously. A 30-cm-long vinylized 
capillary was filled with a mixture composed of 48 μL styrene, 48 μL divinylbenzene, 
130 μL decanol, 20 μL tetrahydrofuran, and 10 μg/μL AIBN. The mixture was 
polymerized in a water bath at 60 ℃ for 20 h. After polymerization, ~2 cm of the 
capillary at both ends was cut off and discarded. The monolith was then rinsed with 
acetonitrile at ~800 psi for 4 h and deionized water at ~1500 psi for 1 h. 
 
4.2.3 Preparation of Ion Exchange (IEX) Monolith 
A 30-cm-long piece of vinylized capillary (250 μm i.d. × 360 μm o.d.) was filled 
with a mixture comprising 225 μL GMA, 75 μL EDMA, 250 μL 1-propanol, 400 μL 
1,4-butadiol, 50 μL deionized water, and 10 μg/μL AIBN. The polymerization was 
processed in a water bath at 60 ℃ for 16 h. After ~2 cm of the capillary at both ends 
was cut off, the monolith was washed with methanol at 800 psi for 4 h.Tertiary-amine 
groups were then created in the monolith via a ring-opening reaction of epoxy groups. 1 
M diethylamine in methanol was pressurized through the above monolith in an oven at 
75 ℃ with a 500-psi pressure for 2 h. The modified monolith was then flushed with 
methanol at room temperature with methanol at 800 psi for 1 h and deionized water at 
1500 psi for 30 min. 
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4.2.4 Sample Preparation 
2.0 mg/mL stock solutions of protein standards were prepared by dissolving the 
appropriate amount of protein powder in deionized water. The stock solutions were 
stored at a ultra-low temperature freezer. Test solutions were produced by diluting the 
stock solution to the desired concentrations with the mobile phase A for IEX or RP-
HPLC. 
The E. coli [a transformant of BL21(DE3) competent cell] was grown in a 
complete Luria-Bertani medium at 37 ℃ overnight. Bacteria cells were harvested by 
centrifugation at 13,000 rpm for 5 min. Approximately 800 mg of wet bacteria pallet 
was suspended in 10 mL chilled sample buffer at pH ~7.6 containing 50 mM Tris-HCl, 
1 mM EDTA, and 1 mM 2-mercaptoethanol. The suspended cells were finally sonicated 
in an ice bath by 3 cycles of 30s bursts with 30s cooling intervals (amplitude 55%, cycle 
0.5 in a Branson Sonifier 450 W). The soluble proteins in the supernatant were collected 
by centrifugation at 13000 rpm for 10 min. The obtained protein lysates were directly 
analyzed without further purification. 
 
4.2.5 Online 2D HPLC Platform 
Figure 4.9 represents a schematic diagram of our 2D HPLC platform. It consisted 
of two gradient pumps (RP Pump – Agilent 1200 Series Binary Pump, and IEX Pump –
Dionex GP50 Gradient Pump), one isocratic pump (ISO pump – Jasco PU-1580 
Intelligent Pump), one 20μL injector, two flow-through stream selectors (Valco 
Instruments, Houston, TX), and three UV   detectors (Linear Instruments, Reno, NV). 
IEX Pump was used for gradient IEX and RP Pump for RP HPLC separations. ISO 
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Pump was used for equilibrating columns with an equilibration solution. In the first-D, 
intact proteins were separated using a laboratory-made IEX monolith column, and the 
effluent was injected directly, continuously and alternately into the three second-D RP-
HPLC columns. 
 
4.2.6 2D HPLC Separation 
All three second-D columns were washed with an equilibration solution [5% (v/v) 
acetonitrile and 0.2% (v/v) tetrafluoric acid in DI water] for five minutes before a 2D 
HPLC separation was started. Once the gradient separation in the first-D was initiated (t 
= 0 min), the system was set to a configuration as shown in Figure 4.9A. From t = 0 min 
to t = 5 min, the first-D effluent was loaded into RP #1 column while an equilibration 
solution was flushing through RP #3 column and a gradient eluent was running through 
RP #2 column. From t = 5 min to t = 15 min, the left stream selector was switched to 
Position 3 (see Figure 4.9B). While the first-D effluent was still loaded into RP #1, an 
equilibration solution was driven through RP #2 to prepare it for sample loading. At this 
time, a gradient eluent was running through RP #3; if RP #3 had been loaded with a 
sample, a gradient elution would have started by now. From t = 15 min to t = 20 min, 
the right stream selector was switched to Position 5 (see Figure 4.9C). The first-D 
effluent was now loaded into RP #2, while an equilibration solution was flushing 
through RP #1 to wash away the matrix (including IEX eluent) from sample loading. At 
this moment, a gradient eluent was still running through RP #3. From t = 20 min to t = 
25 min, the left stream selector was switched to Position 5 (see Figure 4.9D). While the 
first-D effluent was still loaded into RP #2, gradient separation in RP #1 started. At this 
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time, an equilibration solution was flushing through RP #3 to get it ready for sample 
loading. From t = 25 min to t = 35 min, the right stream selector was switched to 
Position 1 (see Figure 4.9E). The first-D effluent was now loaded into RP #3, an 
equilibration solution was flushing through RP #2 to wash away the matrix from sample 
loading, and a gradient eluent was running through RP #1 for separation. From t = 35 
min to t = 40 min, the left stream selector was switched to Position 1 (see Figure 4.9F). 
The first-D effluent was still loaded into RP #3, gradient eluent was running through RP 
#2, and an equilibration solution was flushing through RP #1 to get it ready for sample 
loading. After 45 min, the operation cycled back to the configuration as shown in Figure 
5A. 
As a result of the above operation, every column was loaded with the first-D 
effluent (or sample) for 15 min, washed with the equilibration solution for 5 min, eluted 
with the RP gradient for 15 min, and washed again with the equilibration solution for 10 
min before being loaded with another sample. 
 
4.3 Results and Discussion 
 
4.3.1 RP-HPLC separation 
In our second-D (RP-HPLC) separation, we used a multi-step protocol, i.e., 
sample loading, matrix washing, analyte elution, and column equilibration. A column-
equilibration step was important because the residual RP gradient in the column would 
mess up with the sample loading. The matrix washing step was also important because 
some matrix compounds such as lipids and carbohydrates interfered with RP-HPLC 
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separation and absorption detection. This step would be critical if MS was used as a 
detector because the first-D eluent contained a lot of salt that interferes with MS 
measurements. 
 
4.3.2 Column preparation for 2D HPLC 
Columns for separating intact proteins rarely perform as well as those for peptides. 
Initially, we attempted to utilize commercial columns for both dimensions, but the 
separation results were not satisfactory. Therefore, we developed our own capillary 
(250-μm i.d.) monolithic columns. An IEX column was used for the first-D and 
multiple RP columns were used for the second-D. The IEX column was prepared using 
a two-step procedure. Briefly, a co-polymer monolith was first synthesized by in-situ 
polymerization of GMA and EDMA in a 250-μm i.d. vinylized capillary. Tertiary-
amine groups were then introduced into the monolith to serve as weak anion-exchanger 
via a ring-opening reaction of the epoxy groups. Figure 4.5 presents two chromatograms 
when this column was used to separate a standard protein mixture and a protein lysate 
sample from E. Coli cells. Baseline separation is achieved for the standard protein 
mixture (see Figure 4.5A) while more than 70 peaks were identifiable for the E. Coli 
lysates (see Figure 4.5B); these are excellent results for separating proteins using 
monolith columns. Optimizations and characterizations of these columns will be 
reported in details elsewhere. 
RP columns were PS/DVB-based monolithic columns, and they were prepared 
following a procedure published previously. Both standard proteins and E. Coli cell 
lysates were separated using this column; high quality results were obtained as well (see 
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Figure 4.6). Varied performances between the second-D columns had been a concern 
for us because that would make it difficult to compile all second-D chromatograms into 
one 2D image. This concern was removed as long as we kept the conditions the same in 
preparing the RP columns. Figure 4.1 presents the performance comparison between 
columns of the same batch and Figure 4.2 shows the comparison between columns from 
different batches using the same sample; similar performances were obtained. 
  
Figure 4.1. Column-to-column reproducibility in RP HPLC. Three monolithic 
columns were simultaneously made in the laboratory. Each column was of 20-cm 
length, 360-µm o.d. and 250-µm i.d.. Mobile phase A, 5% (v/v) acetonitrile and 
0.05% (v/v) tetrafluoric acid in DDI water; mobile phase B, 90% (v/v) acetonitrile 
and 0.05% (v/v) tetrafluoric acid in DDI water. Gradient, as indicated with the 
dashed line in the figure; detection, UV at 280 nm; injection volume, 50 nL; 
sample, a mixture of ribonuclease a (a), insulin (2), cytochrome c (3), lysozyme (4), 
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α-lactalbumin (5), transferrin (6), conalbumin (7), myoglobin (8), β-lactoglobulin b 
(9) & a (10); each at 200 μg/mL; pressure on column, ~1100 psi. 
    
Figure 4.2 Batch-to-batch reproducibility in RP HPLC. Three batches of 
monolithic monolithic columns were made in different days. All experimental 
conditions were as in Figure 4.1. 
 
4.3.3 Second-D separation speed consideration 
A conventional 2D HPLC system usually consists of one first-D column and one 
second-D column. In a comprehensive 2D separation, the first-D effluent is 
continuously segmented and injected into the second-D column for analysis. If the 
separation time of the first-D is t and its effluent is segmented into n fractions, the 
separation time for the second-D should be t/n or less. This constraint imposes a great 
challenge for utilizing optimum conditions for both separation dimensions. 
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Here we present an example showing the adverse effect of this constraint. As can 
be seen in Figures 4.5 and 4.6, both IEX and RP columns exhibited reasonable 
resolving power for intact proteins under optimized conditions. In order to retain the 
resolution of the first-D, we would like to segment its effluent into 100 aliquots for the 
second-D separations. We would also like to run the second-D separations in a 
continuous fashion, i.e., no fractionated solution parking. If one IEX column and one 
RP column were used for the first- and second-D, we would have to finish each second-
D separation in less than 2 min based on the chromatogram in Figure 4.5. Figure 4.3 
presents three chromatograms of different gradient ramp rates; resolutions deteriorated 
seriously as the ramp rate increased. Apparently, we could not utilize any parameters 
close to optimized conditions in such a 2D HPLC system. 
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Figure 4.3 Separation of protein lysates from E. Coli cells with RP HPLC. Three 
different gradients were used to demonstrate the effect of the gradient ramp rate 
on the separation performance. The gradient was indicated with the dashed line in 
its corresponding figure. Sample, 70-fold diluted protein lysates from E. Coli cells. 
All other conditions were as in Figure 4.1. 
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4.3.4 Use of multiple columns to address second-D speed demand 
A possible solution to mitigate the speed constraint is to incorporate parallel 
columns in the second-D so that the first-D effluent can be analyzed simultaneously by 
multiple columns. For the aforementioned example, if we could arrange 20 columns in 
the second-D to run separations simultaneously, the time required for each separation 
would increase to 40 min, which would allow us to utilize the optimized separations 
conditions in both dimensions. 
To demonstrate the feasibility of this approach, we incorporated three columns in 
the second-D. Only three second-D columns would not allow us to run both separation 
dimensions at their optimized conditions. As a compromise for this three-second-D 
column setup, we extended the first-D separation to 10.5 h and shortened the second-D 
separation to 15 min. With this set of conditions, we could fractionate the first-D 
effluent into 42 fractions. Figure 4.7 presents the 2D separation results for E. Coli cell 
lysates; greater than 500 peaks were obtained, even only three second-D columns were 
incorporated. It should be pointed out that different gradients were used for the second-
D separations in this experiment, and the detailed gradient conditions are listed in Table 
4.1. 
 
4.3.5 Sample complexity reduction after 2D separation 
To determine the sample complexity after 2D separation, the effluents from the 
second-D were collected and analyzed by SDS–PAGE. As shown in Figure 4.8, several 
bands were observed in SDS–PAGE, indicating that multiple proteins still existed in 
each of these samples. The magnificent point was that only several bands were observed 
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in any lane; compared to hundreds or thousands of proteins in the original sample. The 
sample complexities were greatly reduced! These samples can be conveniently analyzed 
by MS. We anticipate the number of proteins in each sample would reduce 
proportionally with the increasing number of the second-D columns. 
 
4.4 Conclusion 
We have coupled IEX (the first-D) chromatography with multiple-column RP 
(the second-D) chromatography for comprehensive and 2D separation of intact proteins. 
With n columns incorporated in the second-D, we can theoretically reduce the speed 
requirement of the second-D by a factor of n. To demonstrate the feasibility of this 
approach, we have incorporated three second-D columns, and we have reduced the 
speed requirement of the second-D by a factor of 3. This system has been tested for 
separating both protein standards and E. Coli lysates; baseline resolutions were obtained 
for separating 12 standard proteins (see Figure 4.4) while more than 500 protein peaks 
were detected for the E. Coli lysate sample. We have collected the second-D effluents 
from separating E. Coli lysates and analyzed these samples by SDS-PAGE. Only 
several proteins were found in each of these samples, and these samples can be easily 
analyzed by MS or other techniques. It is logic to believe that the number of proteins in 
each sample would further decrease as the number of the second-D columns increase. 
This approach could potentially be an excellent technique for reducing the complexities 
of real-world proteomic samples. However, it is currently a challenge to integrate a 
multiple-column HPLC with a mass spectrometer. 
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Figure 4.4 Testing the 2D HPLC platform with protein standards. (A) Separation 
of protein standards with RP HPLC. Gradient, as indicated with the dashed line in 
the figure; sample, a mixture of ribonuclease a (1), ovalbumin (2), insulin (3), 
cytochrome c (4), lysozyme (5), α-lactalbumin (6), transferrin (7), trypsin inhibitor 
(8), myoglobin (9), conalbumin (10), β-lactoglobulin b (11) & a (12); each at 4 
μg/mL; all other conditons were as in Figure 4.1. (B) Separation of protein 
standards with IEX chromatography. The column was a monolithic one made in 
laboratory. It was of 20-cm length, 360-µm o.d. and 250-µm i.d.. Mobile phase A, 
10 m M Tris/HCl at pH ~7.6 in DDI water; mobile phase B, 1 M NaCl dissolved in 
mobile phase A. Gradient, as indicated with the dashed line in the figure; detection, 
UV at 280 nm; injection volume, 20 μL; sample, a mixture of ribonuclease a (1), 
ovalbumin (2), insulin (3), cytochrome c (4), lysozyme (5), α-lactalbumin (6), 
transferrin (7), Trypsin inhibitor (8), myoglobin (9), conalbumin (10), β-
lactoglobulin b (11) & a (12); each at 50 μg/mL; pressure on column, ~1900 psi. (C) 
Separation of standard proteins with the new developed 2D HPLC platform. The 
second-dimension chromatograms was stacked side by side in the order of fraction 
number, which was assembled using Origin. Injection volume, 20 μL; sample, a 
mixture of ribonuclease a (1), ovalbumin (2), insulin (3), cytochrome c (4), 
lysozyme (5), α-lactalbumin (6), transferrin (7), Trypsin inhibitor (8), myoglobin 
(9), conalbumin (10), β-lactoglobulin b (11) & a (12); each at 4 μg/mL. The length 
of each RP column, and IEX column was 20 cm. The pressure was ~3500 psi on 
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IEX Pump and ~1100 psi on RP Pump. The gradients for the first and second 
dimensions were as in Figure 4.4A and 4.4B, respectively. 
 
                             Table 4.1 Gradients used in the second dimension. 
Fractions	 Gradients,	%	MPB	
1	–	7	 25	–	55	
8	–	14	 28	–	58	
15	–	21	 31	–	61	
22	–	28	 34	–	64	
29	–	35	 37	–	67	
36	–	42	 40	–	70	
	
MPA,	5%	(v/v)	acetonitrile	and	0.05%	(v/v)	tetrafluorci	acid	 in	DDI	water;	MPB,	
90%	 (v/v)	 acetonitrile	 and	 0.05%	 (v/v)	 tetrafluorci	 acid	 in	 DDI	 water.	 14-min	
gradients	were	used	for	protein	separations	and	the	pump	was	conditioned	with	
MPA	for	one	minute	between	two	gradients.	
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Figure 4.5 Performance of IEX chromatography. (A) Separation of protein 
standards. The column was a monolithic one made in laboratory. It was of 20-cm 
length, 360-µm o.d. and 250-µm i.d.. Mobile phase A, 10 m M Tris/HCl at pH ~7.6 
in DDI water; mobile phase B, 1 M NaCl dissolved in mobile phase A. Gradient, as 
indicated with the dashed line in the figure; detection, UV at 280 nm; injection 
volume, 20 μL; sample, a mixture of a-lactalbumin (1), trypsin inhibitor (2), 
phosphorylase b (3), carbonic anhydrase (4), ovalbumin (5), and transferrin (6); 
each at 0.3 μg/mL; pressure on column, ~1200 psi. (B) Separation of protein lysates 
from E. Coli cells. The pressure on the column was ~1900 psi. All other conditions 
were as in Figure 4.5A. 
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Figure 4.6 Performance of RP HPLC. (A) Separation of protein standards. The 
monolithic column was of 20-cm length, 360-µm o.d. and 250-µm i.d. and it was 
made in laboratory. Mobile phase A, 5% (v/v) acetonitrile and 0.05% (v/v) 
tetrafluoric acid in DDI water; mobile phase B, 90% (v/v) acetonitrile and 0.05% 
(v/v) tetrafluoric acid in DDI water. Gradient, as indicated with the dashed line in 
the figure; detection, UV at 280 nm; injection volume, 50 nL; sample, a mixture of 
ribonuclease a (a), insulin (2), cytochrome c (3), lysozyme (4), α-lactalbumin (5), 
transferrin (6), conalbumin (7), myoglobin (8), β-lactoglobulin b (9) & a (10); each 
at 200 μg/mL; pressure on column, ~1100 psi. (B) Separation of protein lysates 
from E. Coli cells. The gradient was indicated with the dashed line in the figure. 
Detection, UV at 210 nm. Sample, 70-fold diluted protein lysates from E. Coli cells. 
Pressure on column, ~1100 psi; all other conditions were as in Figure 4.6A. 
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Figure 4.7 Separation of protein lysates from E. Coli cells using the 2D HPLC 
platform. Present a scale-bar in the figure for UV absorbacne. Also change 
“fraction number” to “number of second-D separation”. Sample – E. Coli cells 
lysates; IEX and RP column length – 20 cm; Separation pressure for the first-D: 
3500 psi; Separation pressure for the second-D: 1100 psi; The first-D gradient: 
[NaCl] increased linearly from 0–0.5 M in 600 min, increased from 0.5–1 M in 0.1 
min, and kept at 1 M for 30 min; The first-D injection volume: 20 μL; The 
gradients for the second-D separations are presented in Table 4.1. 
 
	
83 
		 	
Figure 4.8 Typical sample complexity after 2D HPLC separation.  Bottom: a 
second-D chromatogram (the seventh RP separation from Figure 4.7); Top: SDS-
PAGE results of six effluent fractions (the fractions were collected from 8 – 15 min 
retention time, and each fraction was collected for 70 s). Electrophoretic 
separation was performed using Mini-PROTEIN® Electrophoresis System (Bio-
Rad, Hercules, CA) at 200 volts for 40 min. The gel contained 12% acrylamide. 
The image was created using silver stain. The positions of the sample in the SDS-
PAGE gel image matched vertically with the retention time of the chromatogram. 
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Figure 4.9 Schematic diagram of the new developed 2D-HPLC-UV/Vis platform. 
IEX Pump – Dionex GP50, a gradient pump for IEX chromatography; RP Pump – 
Agilent 1200, a gradient pump for reverse-phase high performance liquid 
chromatography; ISO Pump – Jasco PU1580, an isocratic pump for column 
equilibration; IEX – monolithic column for IEX chromatography; RP #1, #2, and 
#3 – three parallel monolithic columns for reverse-phase high performance liquid 
chromatography. RC represents restriction capillaries, which are used to control 
the back pressure on respective columns. 
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Chapter 5: 2-µm-i.d. capillary liquid chromatography for high 
resolution and efficiency separation of peptides 
 
5.1 Introduction 
Open tubular columns were first applied for liquid chromatography (LC) by 
Tsuda et al. in 1978, using an 60 μm i.d.  tube32. Later, the first research about open 
tubular columns with an small inner diameter close to 15 μm was reported by Jorgenson 
and Guthrie93. They developed Chemical medication of the surfaces to prepare Open 
tubular capillary LC columns, which suffered from low retention and low sample 
loading capacity.  
To increase sample loading capacity, porous layer open tubular (PLOT) columns 
has been studied in the last 30 years to provide improved capillary LC columns31, 94-96, 
which has been shown a higher separation efficiency than conventional packed columns. 
But the success of PLOT was limited due to the major challenge of casting a uniform 
porous layer on the capillary. Several methods have been developed to generate a 
retentive layer, two- step coating methods include static97, dynamic98, 99and precipitation 
coating100and one step procedure was developed via sol-gel process 101. Polymeric 
PLOT columns have been developed in two different strategies. The first strategy is to 
first prepare polymer particles, which are chemically anchored onto the capillary inner 
wall in the second step102, 103. In the second strategy, the polymer is produced on the 
capillary inner wall by in-situ polymerization 104, 105. PLOT polystyrene divinylbenzene 
(PS-DVB) columns as the most popular Polymeric PLOT columns, have been used for 
high resolution, ultra-trace separation of peptides and intact proteins106, 107. This one 
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step method significantly improves the reproducibility in producing columns but it is 
not practical in producing a polymer layer in the very narrow-bore capillary.  
In order to overcome the band broadening caused by the laminar flow in the open 
tubular capillary, capillaries of 5-10 μm i.d. were early considered to be necessary for 
open tubular LC. Theory already predicted that open tubular columns have a maximum 
efficiency when the i.d. is ~ 2 μm 93. On chip-based platform, a highly efficient 
separation (440000 plates/ m) by pressure-driven liquid chromatography in extended 
nanochannels has been achieved108. To the best of my knowledge, using HPLC format 
no capillary of i.d smaller than 5 μm has been applied for open tubular LC due to 
experimental limitations such as low sensitivity and difficulties in the preparation of 
retentive layer in the capillary of i.d smaller than 5 μm.      
In this work, an open tubular LC was made by using 2 μm i.d. capillary, which is 
close to the dimension of single pathway in the conventional packed column. Because 
of the small bore, the only chemical modification on the inner wall of the capillary can 
provide high ratio of stationary phase to mobile phase, leading to high retentive ability. 
The clogging issues, which often occurred in preparation of retentive layer via 
polymerization in small-bore capillaries, were fixed by innovatively using chemical 
grafting modification. The separations of amino acids and peptides using this column 
result in a high resolution, fast separation and high separation efficiency. The study of 
the 2 μm i.d. single pore chromatography can potentially become an optimal model for 
exploring fundamental behaviors in liquid chromatography.     
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5.2 Experimental section 
 
5.2.1 Reagents and Materials 
Elven amino acids (histidine, asparagine, glycine, arginine, tyrosine, trytophan, 
alanine, phenylalanine, leucine, valine and, isoleucine), peptide standard mixture, 
trimethoxy(octadecyl)silane, toluene, and bovine serum albumin (BSA) were all 
purchased from Sigma (St. Louis, MO). Sequencing Grade Modified Trypsin was 
purchased from Promega (Madison, WI). Fused silica capillaries were purchased from 
Polymicro Technologies (Phoenix, AZ). ATTO-TAG™ FQ Amine-Derivatization Kit 
was the product of ThermoFisher Scientific (Lafayette, Co). All solutions were prepared 
with double-deionized (DDI) water purified by a NANOpure infinity ultrapure water 
system (Barnstead, Newton, WA). 
 
5.2.2 Apparatus 
The experimental setup is schematically shown in Figure 5.1. The flow driven by 
HPLC pump was split by a peek tee. A 20 cm capillary of 50 μm i.d. was used as the 
splitting capillary, which determined the flow rate in the downstream of the system. The 
dwell time can be adjusted by changing this capillary. The second peek tee was used to 
connect 180 μm i.d. and 360 μm o.d. capillary with 2 μm i.d. and 150 μm o.d. column. 
The small o.d. column passed through the second tee with a small portion inserted into 
the 180 μm i.d. and 360 μm o.d. capillary to avoid dead volume between these two 
capillaries.  A 10 cm capillary of 20 μm i.d. was used as splitting capillary in the second 
tee to control the amount of sample injected into the 2 μm i.d. and 150 μm o.d. column.  
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5.2.3 HPLC procedures 
HPLC separation was performed using the pump from Angilent 1200 system. 
Mobile phase A, 10 mM NH4HCO3in DDI water; mobile phase B, acetonitrile were 
used for gradient separation. The configuration of the nanoLC/LIF system using the 2 
μm i.d. column is shown in figure 5.1. 2 μL of sample was injected by using a six port 
injection valve (VICI, TX, USA). Two peek tees were used as splitters; one was used 
for splitting the main stream from the pump, and the other for splitting the stream out 
from the injection valve. A small portion of 2 μm i.d. and 150 μm o.d. column was 
inserted into 180 μm i.d. and 360 μm o.d. capillary to avoid dead volume between these 
two capillaries. The polyimide coating of inserted portion was removed because it 
would fall off after soaking in organic containing solution for a long time. At 4 cm 
away from the end of the 2 μm i.d. column, a detection window was made by peeling 
off ~1 cm long polyimide coating for LIF detection.  
 
5.2.4 Preparation of capillary 
A capillary of o.d. of 150 μm and an i.d. of 2 μm was flushed with 1 M NaOH 
at 100 ℃ for 2 h and then washed with DDI water of at least 5 times of capillary 
volume. Rinse the capillary with acetonitrile of 3 times of capillary volume, followed 
by drying with nitrogen gas for one hour. Then the capillary was flushed with a mixture 
of 50 μL trimethoxy(octadecyl)silane and 50 μL toluene at 50 ℃ for 16 h, followed 
by toluene wash of at least 5 times of capillary volume.  Nitrogen gas was finally used 
to dry the capillary before use. 
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5.2.5 Fluorescence Labeling of Amino acids and peptides 
According to the instruction of ATTO-TAG™ FQ Amine-Derivatization Kit, 5.0 
mg of ATTO-TAG FQ was dissolved in 2.0 mL of methanol to make a 10 mM stock 
solution. A 0.20 M KCN stock solution was prepared by dissolving 20 mg of KCN in 
1.5 mL of ultrapure water. Working KCN solution (10 mM) was prepared just before 
use. Amino acid stock solutions (each containing 1 mM of one amino acid) were 
prepared in ultrapure water. A volume of 1.0 µL of the amino acid stock solution was 
mixed with 4.0 µL of 10 mM pH 9.2 Borax solution, 10 µL of the 10 mM KCN 
working solution, and 5 µL of the 10 mM FQ solution in a vial, and this mixture was 
maintained at room temperature under light protection for 1 h before. The resulting FQ-
labeled-amino acid was diluted with ultrapure water prior to analysis. A tryptic digest of 
BSA protein was used for peptides labeling. The digestion of BSA was performed as 
follows: 52 µL of filtered 10 mg/ml BSA was mixed with 10 µL of Trypsin solution, 20 
of µL filtered 500 mM NH4HCO3, 1 µL 1 M DTT, and 117 µL ultrapure water. The 
mixture was kept at 37 ℃ for 8 hours before labeling. 5 µL of digestion mixture mixed 
with 10 µL of 10 mM KCN working solution, and 5 µL of the 10 mM FQ solution in a 
vial was maintained at room temperature under light protection for 1 h prior to analysis.    
 
5.3 Results and discussion 
Figure 5.3 presents chromatograms under different elution pressures. The zoom-
in chromatograms were placed on the right accordingly. While the separation speed 
increased, the separation efficiencies decreased (see Fig. 5.3B) with the increasing 
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elution pressure. We used the half height width of each peak to calculate theoretical 
plates per meter. At 300 psi, all 11 peaks of amino acids had efficiencies over 800,000 
theoretical plates per meter, 5 of them (Histidine (1), Asparagine (2), Glycine (3), 
Tryptophan (7), Isoleucine (9)) had efficiencies over 2 million plates per meter, and the 
separation efficiency of Isoleucine amazingly reached over 10 million plates per meter 
in just 10 min. No efficiency result was shown for tyrosine (4), Arginine (5) at 900 psi 
and 1200 psi because these two peaks merged into one peak at high pressure. Even at 
1250 psi when 11 peaks were eluted out in less than 2.5 min, the efficiencies of 7 peaks 
had more than 400,000 plates per meter. To my best knowledge, these efficiencies are 
exceptionally high for fast separation and had never been achieved by chromatography.  
Figure 5.2 shows the gradient elution was applied to separate these 11 amino 
acids. Compared to the isocratic elution at 300 psi, the gradient elution made better and 
faster separation and all peaks were uniformly sharp as expected.  
Besides separation of amino acids, this column was also able to efficiently 
separate more complicated sample, trypsin-digested protein. Peptides were retained on 
the column and resolved as well as amino acids. Gradient elution was applied to the 
separation of the peptides sample. Peptides were more retentive than amino acids, 
therefore the gradient with higher elution strength was applied. Referring to peak 
capacity optimization109, the optimum flow rate varies substantially with gradient time 
when the other factors are held constant. So we first optimized gradient time. Figure 5.4 
shows chromatograms using different gradient times.  The peak capacity increased with 
the gradient time. In only 15 min separation (corresponding to 10 min gradient time), 
~40 peaks from trypsin digested BSA sample were obtained, which required more than 
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40 min by conventional packed column. 10 min gradient time was picked after 
compromising the time and separation efficiency. Then pressure applied on the column 
was further optimized with 10 min gradient time. 675 psi was chosen as the optimal 
pressure for this gradient time based on the separation shown in figure 5.5. These 
optimized pressure and gradient were finally applied for separation of BSA and 
Myoglobin trypsin digest. In less than 15 min, more than 60 peaks from both digest 
were separated as shown in figure 5.6. A peak capacity calculation based on the average 
peak width 10% height ~2s resulted in an average value of 300 expected peak capacity, 
which shows a potential capacity for more complicated sample in a fast separation. 
Figure 5.7 shows the comparison of separation efficiency between i.d. 5 µm and 
i.d. 2 µm capillaries. The same column preparation process was applied to different i.d. 
capillaries, so the formation of stationary phase was expected to be identical in different 
i.d. capillaries, which resulted in the same dimension of stationary phase.  With bigger 
cross section area, the i.d. 5 µm capillary had a much smaller ratio of stationary phase to 
mobile phase than i.d. 2 µm, which leaded to undesirable partition of the solutes 
between two phases. As a result, under the same linear velocity the i.d. 2 µm has much 
better separation of 11 amino acids than i.d. 5 µm capillary.  
 
In conclusion, we have developed a fast and exceptionally high efficient single 
pore capillary LC to resolve amino acids and peptides; in only ten minutes separation 
efficiencies of more than ten millions plates per meter are already obtained. For this 
narrow capillary, the on-line detection, avoiding the dead volume from the post column 
detector, contributes a lot to the high separation efficiency. Complicated protein trypsin 
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digested sample are used to demonstrate the high efficient separation of peptides, which 
proves the potential of this technology to be excellent alternative separation method for 
the proteomic study. Due to the use of narrow capillaries, attention is needed to avoid 
capillary clogging. LIF detector is required to meet the low detection limit of the narrow 
capillaries. With the development of interface for extremely low flow rate ESI-MS, we 
are going to combine this separation technique with MS to make an outstanding 
alternative technique to conventional LC-MS for proteomic research. 
 
  
Figure 5.1 Schematic diagram of the single channel LC system. Full details are in 
the experimental section. 
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Figure 5.2 Comparison of isocratic and gradient elution. The separation column 
was of 48-cm total length and 44-cm effective length, 150-µm o.d. and 2-µm i.d. 
Gradient elution: Mobile phase A, 10 mM NH4HCO3 in DDI water; mobile phase 
B, acetonitrile. Gradient, 0-50% mobile phase B in 1.5 min, 50% B for 0.5 min 
then down to 0% in 3.5 min; Isocratic elution: 20% mobile phase B. Injection 
volume, 2μL; sample, a mixture of Histidine (1), Asparagine (2), Glycine (3), 
tyrosine (4), Arginine (5), Alanine (6), Tryptophan (7), Valine (8), Isoleucine (9), 
Phenylalanine(10), Leucine(11); each at 6.5 μM; pressure on column, ~300 psi. 
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Figure 5.3 Effect of pressure on separation. The separation column was of 48-cm 
total length and 44-cm effective length, 150-µm o.d. and 2-µm i.d. Gradient 
elution: Mobile phase A, 10 mM NH4HCO3 in DDI water; mobile phase B, 
acetonitrile. Isocratic elution: 20% mobile phase B. Injection volume, 2μL; sample, 
a mixture of Histidine (1), Asparagine (2), Glycine (3), tyrosine (4), Arginine (5), 
Alanine (6), Tryptophan (7), Valine (8), Isoleucine (9), Phenylalanine(10), 
Leucine(11); each at 6.5 μM; various pressures applied on column. 
   
Figure 5.4 Effect of gradient time on separation. The separation column was of 48-
cm total length and 44-cm effective length, 150-µm o.d. and 2-µm i.d.. Mobile 
phase A, 10 mM NH4HCO3in DDI water; mobile phase B, acetonitrile. Gradient, 0-
82.5% mobile phase B in different gradient times, injection volume, 2μL; sample, 
digestion of 0.62 mg/mL BSA; pressure on column, ~600 psi. 
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Figure 5.5 Effect of separation pressure when gradient time is constant. The 
separation column was of 48-cm total length and 44-cm effective length, 150-µm 
o.d. and 2-µm i.d.. Mobile phase A, 10 mM NH4HCO3in DDI water; mobile phase 
B, acetonitrile. Gradient, 0-82.5% mobile phase B in 10 min, injection volume, 
2μL; sample, digestion of 0.62 mg/mL BSA; pressure on column were various. 
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Figure 5.6 Separation of mixture of BSA trypsin digest and Myoglobin trypsin 
digest. The separation column was of 48-cm total length and 44-cm effective 
length, 150-µm o.d. and 2-µm i.d.. Mobile phase A, 10 mM NH4HCO3 in DDI 
water; mobile phase B, acetonitrile. Gradient, 0-82.5% mobile phase B in 10 min, 
injection volume, 2μL; sample, digestion of 0.62 mg/mL BSA; pressure on 
column~675 psi. BSA trypsin digest and Myoglobin trypsin digest were separated 
respectively, followed by the separation of mixture of both trypsin digests.   
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Figure 5.7 The effect of inner diameter of capillary on separation. The separation 
column of i.d. 5 μm or 2 μm was of 48-cm total length and 44-cm effective lengths, 
and150-µm o.d. Mobile phase A, 10 mM NH4HCO3in DDI water; mobile phase B, 
acetonitrile. Isocratic, 20% mobile phase B. Injection volume, 2μL; sample, a 
mixture of Histidine (1), Asparagine (2), Glycine (3), tyrosine (4), Arginine (5), 
Alanine (6), Tryptophan (7), Valine (8), Isoleucine (9), Phenylalanine(10), 
Leucine(11); each at 6.5 μM for 2 μm i.d. capillary;0.3 μM for 5μm i.d. capillary; 
pressure on 2 μm i.d. column, 600 psi and pressure on 5 μm i.d. column, 100 psi. 
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Chapter 6: Conclusion and future directions 
 
6.1 Conclusions 
Capillary-based analytical techniques have broad applications in separation of 
biomolecules (DNA, amino acids, peptides, and proteins). The small dimension of 
capillary allows small amount of sample analysis and high voltage application. In the 
extremely narrow capillary, we are not surprised to discover some special separation 
behaviors, which result in unusually good separation resolution and efficiency. The 
special chemical property of the inner wall of capillary gives an interaction with a DNA 
dye, which was used to develop a simple on-line DNA labeling method. Then the on-
line DNA analysis by coupling on-line labeling, PCR, and bare narrow capillary – 
hydrodynamic chromatography provides us a way to make a portable platform for 
point-of-care applications. With high voltage applied, the isoelectric point based 
fractionation of protein took place in a capillary, which provides us a simple method to 
purify or fractionate a protein sample for MS analysis because the method is MS 
friendly by not using carrier ampholytes. Monolithic capillary columns are successfully 
prepared for a new 2D-HPLC configuration, which has three columns parallel for 
second dimension separation for reducing the speed requirement of the second-D. More 
capillary columns can be paralleled to further decrease the speed requirement. For open 
tubular capillary separation, the extremely high separation efficiency has been obtained 
in 2 μm i.d. capillary, which cannot be done in 5 μm i.d. capillary. Overall, the 
capillary-based development of technique can provide many outstanding alternatives for 
bio-research.  
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6.2 Future directions 
As analysis of tiny amount of sample for example sample from a single cell, and 
miniaturization and portability of analysis platform are desired, capillary-based 
techniques are required for small sample and reagent consumption, and small size of 
setup. The special separation properties of extremely narrow capillary will be used to 
revolutionize the conventional HPLC column in future.     
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